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Abstract 
 
Today’s pet food industry is growing rapidly, with pet owners demanding high-quality diets 
for their pets. The primary role of diet is to provide enough nutrients to meet metabolic 
requirements, while giving the consumer a feeling of well-being. Diet nutrient composition and 
digestibility are of crucial importance for health and well being of animals. A recent strategy to 
improve the quality of food is the use of “nutraceuticals” or “Functional foods”. At the moment, 
probiotics and prebiotics are among the most studied and frequently used functional food 
compounds in pet foods. 
The present thesis reported results from three different studies.  
The first study aimed to develop a simple laboratory method to predict pet foods 
digestibility. The developed method was based on the two-step multi-enzymatic incubation assay 
described by Vervaeke et al. (1989), with some modification in order to better represent the 
digestive physiology of dogs. A trial was then conducted to compare in vivo digestibility of pet-
foods and in vitro digestibility using the newly developed method. Correlation coefficients 
showed a close correlation between digestibility data of total dry matter and crude protein 
obtained with in vivo and in vitro methods (0.9976 and 0.9957, respectively). Ether extract 
presented a lower correlation coefficient, although close to 1 (0.9098). Based on the present 
results, the new method could be considered as an alternative system of evaluation of dog foods 
digestibility, reducing the need for using experimental animals in digestibility trials. 
The second parte of the study aimed to isolate from dog faeces a Lactobacillus strain 
capable of exert a probiotic effect on dog intestinal microflora. A L. animalis strain was isolated 
from the faeces of 17 adult healthy dogs..The isolated strain was first studied in vitro when it was 
added to a canine faecal inoculum (at a final concentration of 6 Log CFU/mL) that was incubated 
in anaerobic serum bottles and syringes which simulated the large intestine of dogs. Samples of 
fermentation fluid were collected at 0, 4, 8, and 24 hours for analysis (ammonia, SCFA, pH, 
lactobacilli, enterococci, coliforms, clostridia). Consequently, the L. animalis  strain was fed to 
nine dogs having lactobacilli counts lower than 4.5 Log CFU per g of faeces. The study indicated 
that the L animalis strain was able to survive gastrointestinal passage and transitorily colonize the 
dog intestine. Both in vitro and in vivo results showed that the L. animalis strain positively 
influenced composition and metabolism of the intestinal microflora of dogs. 
The third trail investigated in vitro the effects of several non-digestible oligosaccharides 
(NDO) on dog intestinal microflora composition and metabolism. Substrates were fermented 
using a canine faecal inoculum that was incubated in anaerobic serum bottles and syringes. 
Substrates were added at the final concentration of 1g/L (inulin, FOS, pectin, lactitol, gluconic 
acid) or 4g/L (chicory). Samples of fermentation fluid were collected at 0, 6, and 24 hours for 
analysis (ammonia, SCFA, pH, lactobacilli, enterococci, coliforms). Gas production was 
measured throughout the 24 h of the study. Among the tested NDO lactitol showed the best 
prebiotic properties. In fact, it reduced coliforms and increased lactobacilli counts, enhanced 
microbial fermentation and promoted the production of SCFA while decreasing BCFA. All the 
substrates that were investigated showed one or more positive effects on dog faecal microflora 
metabolism or composition. Further studies (in particular in vivo studies with dogs) will be needed 
to confirm the prebiotic properties of lactitol and evaluate its optimal level of inclusion in the diet. 
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1. Introduction 
 
Today’s pet food industry is growing rapidly, with pet owners demanding high-quality 
diets for their pets. This demand is creating a search for new strategies to improve pet foods 
quality and/or  the health status of the animal through the diet. 
In Italy, more than 3 million dogs are registered in the “Anagrafe Canina Nazionale” 
data bank (Anagrafe Canina Nazionale, march 2008), and the estimated real number of dogs 
present is close to 7 million (Zoomark, 2005). In 2004, 454 million of euro were spent in 
Italy for commercial foods for dogs (Zoomark, 2005). Nowadays, pets are kept as part of the 
family and thus pet owners feel responsible for their quality of life and longevity. 
The primary role of diet is to provide enough nutrients to meet metabolic 
requirements, while giving the consumer a feeling of well-being. Recent knowledge, 
however, supports the hypothesis that, beyond meeting nutritional needs, diet may modulate 
various functions in the body and play detrimental or beneficial roles in some diseases. 
Concepts in nutrition are expanding to include an emphasis on the use of foods to promote a 
state of well-being and better health and to help to reduce the risk of diseases. 
Diet nutrient composition and digestibility are of crucial importance for health and 
well being of animals. Although great attention is paid to nutritional quality in the marketing 
of dog foods there is usually limited information on digestibility. The most highly 
recognized dog food brands claim to have optimum nutritional quality and high digestibility, 
without or with few scientific data and no controlled trial to support their statements and 
claims. The pet food industry traditionally uses a wide range of protein sources, including 
meat and bone meals, poultry meals, poultry by-product meals, and soybean meal. 
Significant variation in the nutritional quality of ingredients directly affects the nutritional 
value of the finished product. Moreover, processing of foods can influence the availability 
of nutrients, either positively or negatively.  
A recent strategy to improve the quality of food is the use of “nutraceuticals” or 
“Functional foods”. Nutraceutical (a term coined by the fusion of nutrition and 
pharmaceutical) refers to extracts of foods claimed to have a medicinal effect, while a 
functional food is a part of an everyday diet which is demonstrated to offer health benefits 
and reduce the risk of chronic disease beyond the widely accepted nutritional effects. The 
term ‘functional foods’ was introduced in Japan in mid 1980s. This type of foods is known 
on the Japanese market as “FOods for Specified Health Use” (FOSHU). The functional 
foods comprise: conventional foods containing naturally occurring bioactive substances 
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(e.g., dietary fiber), foods enriched with bioactive substances (e.g., probiotics, antioxidants), 
and synthesized food ingredients introduced to traditional foods (e.g., prebiotics).  
Among the functional components, probiotics and prebiotics, soluble fiber, omega-3 – 
polyunsaturated fatty acids, conjugated linoleic acid, plant antioxidants, vitamins and 
minerals, some proteins, peptides and amino acids, as well as phospholipids are frequently 
mentioned. At the moment, the most studied and frequently used functional food 
compounds in pet foods are probiotics, prebiotics, plant antioxidants and vitamins. 
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2. The digestive tract of dogs 
 
It is well known that a close relationship exists between gastro-intestinal 
characteristics, natural feral diet and nutrient requirements. The gastro-intestinal 
morphology and physiology are greatly influenced by nature of food consumed, frequency 
of meals, body size, and several other factors. Dogs are omnivorous, derived from 
carnivorous ancestors.  
Compared to herbivorous and “earlier” omnivorous species, dog digestive tract is 
relatively short and simple. The average ratio of body length to intestine length of 
carnivorous is 1:6 and 1:4, for dog and cat respectively, compared to an average ratio of 
1:22 for ruminants and of 1:14 for swine (Stevens, 1977). Table 2.1 shows the principal 
measures that characterise the dog gastro-intestinal tract. 
 
Table 2.1: Organ volumes and length in the dog (Stevens, 1977)  
Figure 2.1: Dog gastro-intestinal tract (Stevens, 1977) 
 
The digestive process begins in the mouth. The first 
step of digestion is the secretion of saliva during 
mastication by four pairs of salivary glands. The amount 
and composition of the saliva secreted depends on the type 
of food ingested (particularly the water content). Saliva 
consists of about 99% water, the remaining 1% is made of 
Region Measures 
 Relative length (%) Average absolute length (m) 
Small intestine 85 4.14 
Cecum 2 0.08 
Colon 13 0.60 
Total 100 4.82 
 Relative volume (%) Average absolute volume (L) 
Stomach 62.3 4.33 
Small intestine 23.3 1.62 
Cecum 1.3 0.09 
Colon 13.1 0.91 
Total 100 6.95 
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mucus, inorganic salts (calcium, chloride, potassium, sodium and bicarbonate) and enzymes 
(Maskell & Johnson, 1993). In dog saliva there isn’t the starch digestive enzyme α-amylase. 
 
2.1 Stomach 
 
The stomach controls the rate of entry of ingesta in the small intestine. This fact is 
very important in dogs who tend to eat large meals. The stomach participates in the initial 
stages of digestion by secreting hydrochloric acid and pepsinogen. Electrolyte 
concentrations in the stomach reported in literature vary widely, ranges of reported values 
are shown in Table 2.2.  
 
Table 2.2: Electrolyte composition of gastric juice in dogs (Altman & Dittmer; 1968). 
Electrolyte Range (mmol/L) 
Bicarbonate 5-33 
Potassium 7-28 
Sodium 22-155 
Chloride 123-173 
Calcium 0.5-4 
Phosphate 0.026-12 
Magnesium 0.021 
 
The major enzymes secreted in the lumen of the stomach are gastric lipase and pepsin. 
Gastric lipase, in contrast to pancreatic lipase, is characterized by his high stability and high 
level of activity under acidic pH condition (Carrière et al., 1991). The secretion of gastric 
lipase is stimulated by food ingestion. During the peak output, which happens during the 
first hour after meal, gastric lipase secretion is three times higher than the basal secretion 
rate, with a total output three hours after meal of about 7 mg (Carrière et al., 1993). Pepsin 
range of secretion vary widely among individuals. Pepsin displays optimal activity at pH 2, 
maintained by gastric secretion of hydrochloric acid; its proteolytic activity decreases along 
the small intestine and is completely inactivated at neutral pH. 
Gastric acid secretion data in dogs are reported in Table 2.3 (Dressman & Yamada, 
1991). In dogs, the gastric acid secretion rate at the basal state is low. Therefore, the 
stomach pH can be as high as the duodenal one in the fasted state. Gastric secretion is 
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influenced by the amount of protein in the meal (Carpentier et al., 1977), hormones and the 
nervous system. 
Table 2.4 lists the pH values of different sections of dog gastro-intestinal tract. In the 
stomach, the cardiac region has a higher pH value then the pyloric region, since the parietal 
cells (which secrete hydrochloric acid) tend to be localized in the lower part of the stomach. 
In the small intestine, pH becomes progressively more alkaline in the distal portions. In the 
large intestine, pH values are more acidic due to microbial fermentation.  
 
Table 2.3: Gastric acid secretion data in dogs (Dressman & Yamada, 1991). 
Parameter   
Basal acid output (BAO)   
volume mL/min 0.3-1.5 
rate mEq/h 0.1 
Peak acid output (PAO)   
rate mEq/h 39 
pH   
fasted  1.5 
fed  2.1 
 
Table 2.4: pH values of different parts of the alimentary tract in dogs (Smith, 1965) 
Stomach Small intestine    
Anterior Posterior a b c d Cecum Colon Faeces 
5.5 3.4 6.2 6.2 6.6 7.5 6.4 6.5 6.2 
 
Gastric emptying is the process by which food is delivered to the small intestine at a 
rate and in a form that optimizes intestinal absorption of nutrients. Physiological data 
reported in literature about gastric emptying in dogs comprise a wide range of times, 
ranging from 66 minutes to 29 hours (Wyse et al., 2003). Rates of gastric emptying are 
influenced by many factors related both to animal and diet characteristics. Weber et al. 
(2001) reported a significant positive correlation between gastric emptying time and body 
weight, with a lower gastric retention time of foods in giant breeds. Foods can affect ranges 
depending on their volume, energy content, viscosity, density, and particle size (Mizuta et 
al., 1990; Papasouliotis et al., 1993; Chalmers et al., 2005; Xu et al., 2005).  
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2.2 Small intestine 
 
In dogs, the small intestine is the major site for the digestion and absorption of 
nutrients. Transit of acid chyme from the stomach into the small intestine stimulates the 
secretion of pancreatic juice into the duodenum. Bicarbonates present in the pancreatic juice 
and bile neutralise the acidic pH of digesta. In the duodenum, chyme is mixed with enzymes 
secreted by the exocrine pancreas and the duodenal mucosa. Pancreatic enzymes include 
inactive proteases, lipases, and amylases. The average composition of dog pancreatic juice 
is shown in Table 2.5 (Altman & Dittmer; 1968). The range of values is very wide because 
several factors affect electrolytes and enzymes secretion, as, for example, meal composition 
(Fink et al., 1982; Fink et al., 1983).  
 
Table 2.5: Composition of dog pancreatic juice (Altman & Dittmer; 1968). 
  Value 
pH  7.1 - 8.2 
Secretion rate mL/min 0.2 - 1.1 
Water content  % 98 
Ash content g/L 8.4 - 9.7 
Bicarbonate mmol/L 93 - 143 
Total nitrogen mmol/L 71.4 - 671.4 
 
Besides food, hormones can stimulate the exocrine secretion of the pancreas: secretin 
and cholecystochinin, produced by cells of the intestinal mucosa, regulate the output of 
pancreatic juice. Secretin stimulates the pancreas to increase bicarbonate secretion. Secretin 
release is caused by the acidity of small intestinal contents. Cholecystochinin stimulates the 
release of enzyme-rich juices and is stimulated by the presence of partially digested food in 
the small intestine (Maskell & Johnson, 1993).  
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Table 2.6: Composition of bile secreted from the gallbladder and from the liver of dogs. 
Values are express in g/L. (Altman & Dittmer, 1968) 
 Gallbladder Liver 
pH 5.2 - 7.0 7.1 - 8.5 
Dry matter 114 - 246 23 - 45 
Salts 79 - 150 5 - 24 
Cholesterol 0.8 - 1.4 0.04 - 0.15 
 
The importance of bile fluid in the digestion and absorption of dietary lipids has long 
been recognized. Bile is continuously produced in the liver and stored, between meals, in 
the gallbladder in a concentrate form. Bile from the gallbladder differs in concentration 
from bile secreted directly from the liver (Table 2.6). In dogs, more than 99% of bile acids 
are coniugated with taurine (Wildgrube et al., 1986; Washizu et al., 1990). 
The gallbladder contracts in response to food ingestion. Emptying peaks are found at 
30 min after a meal and the emptying decreases 2 hours after food ingestion; gallbladder 
empties only partially after a meal (5-65%). Half-emptying time has been reported to be 
approximately 47 min (Junderko et al., 1994). In Table 2.7, the rate of bile flow and bile 
composition are given. 
 
Table 2.7: Rate of bile flow and bile composition (Ehrlinger, 1987; Kararli, 1995). 
Parameter  Range 
Bile flow mL/die/kg 19-36 
Total bile salts (TBS) 
rate mmol/die/kg 1.6-2.9 
TBS mmol/L 40-90 
 
  Na mEq/L 141-230 
K mEq/L 4.5-11.9 
Ca mEq/L 3.1-13.8 
Mg mEq/L 2.2-5.5 
Cl mEq/L 31-107 
HCO3 mEq/L 14-61 
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2.3 Large intestine 
 
The last section of the gastrointestinal tract involved in the digestion process is the 
large intestine. The primary role of the large intestine is to absorb electrolytes and water and 
serve as an environment for microbial fermentation of nutrients that escape digestion and 
absorption by the small intestine. The colon represents the majority of the large intestine. 
The large intestine mucosa has no villi and is covered by an alkaline mucus whose function 
is to protect the large intestine mucosa from mechanical and chemical injuries (Maskell & 
Johnson, 1993). Large intestinal transit time in dogs lasts approximately 12 hours (Maskell 
& Johnson, 1993). Weber et al. (2002) studied the influence of body size on intestinal 
transit time in dogs. Despite the relatively lower mass of the gastrointestinal tract found in 
large breed dogs compared to small breed ones (3-4% vs 7-8%; Meyer et al., 1993), Weber 
et al. (2002) found no direct correlation between body size and oro-cecal intestinal transit 
time, while Hernot et al. (2006) demonstrated a positive correlation between large intestinal 
transit time and body size. The efficiency of absorption of salts and water is dependent, to a 
large extent, on colonic motility. Rolfe et al. (2002) demonstrated that a reduction in large 
intestinal transit time decreases the capacity for electrolyte and water absorption and results 
in elimination of watery faeces. On the contrary, longer large intestinal transit time 
promotes colonic fermentation, which has a positive impact on faecal quality (Macfarlane & 
Macfarlane, 2003). 
The large intestine in dogs is responsible for only about 8% of the total digestion of 
food (Drochner & Meyer, 1991), although this percentage is affected by the diet. Meyer & 
Schunemann (1989) reported that colonic digestibility accounted for 1 to 4% of total 
digestibility when dogs were fed highly digestible diets, whereas with diets containing 
certain types of fiber colonic digestibility ranged from 12 to 24% of total digestibility. 
Nutrient digestion in the large intestine is made by colonic bacteria, which ferment dietary 
nutrients and endogenous secretions that escape digestion and absorption in the small 
intestine. 
One of the fundamental properties of mucosal epithelia is their ability to directly 
utilize ‘topical’ nutrients, derived from the diet or the digestion of food, without reliance on 
the blood flow. By the time the digesta reach the colon, however, over 90% of protein and 
carbohydrate has been absorbed, and all that is left is fiber and ‘resistant’ starch and protein. 
Although the gut does not secrete enzymes that are capable of digesting these residues, the 
colonic microbiota does, and in an excellent example of symbiosis, the bacteria metabolize 
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the residues to SCFAs and gases, such as hydrogen and methane, which are chiefly 
absorbed and excreted via the lungs (O’Keefe, 2008). 
The primary end products of bacterial fermentation are SCFAs, lactate, carbon 
dioxide, and hydrogen. Other fermentative end products include hydrogen sulfite, methane, 
ammonia, branched-chain fatty acids, amines, phenols, and indoles. The relative proportion 
of these compounds is influenced by colonic microflora composition, metabolic interactions 
among bacteria, nutrients available for fermentation, intestinal transit time, and a variety of 
host factors including age and immune status (Cummings & Macfarlane, 1991). 
 
2.4 Colonic microbiota 
 
Indigenous intestinal microorganisms play several significant roles in host health 
because they aid in the digestion of food, metabolize drugs and foreign compounds, produce 
essential vitamins, and help prevent pathogens from colonizing the gastrointestinal tract 
(March, 1979; Shanahan, 2002) 
Quantitative and qualitative knowledge of the structure of the bacterial community in 
the intestinal tract is essential to understand the impact on health status of the host. Up to the 
present time, few works exist which describe the intestinal microbiota of dogs (Fujisawa & 
Mitsuoka, 1996; Greetham et al., 2002; Simpson et al., 2002; Mentula et al., 2005; 
Sochodolski et al., 2005; Beasley et al., 2006; Kim & Adachi, 2007). In addition, many of 
these studies are focalized on a restricted number of bacterial species, such as lactic acid 
bacteria.  
The colon contents of dog support at least 400 different species, with numbers as high 
as 1010 and 1011 viable bacteria/g of digesta (Davis et al, 1977). Bacterial counts reported in 
Table XX are extrapolated from data by Simpson et al. (2002). The main cultivable 
bacterial groups in dogs include clostridia, Bacteroides, streptococci, coliforms, enterococci 
and lactobacilli with increasing counts towards the large intestine (Davis et al., 1977; 
Greetham et al., 2002, Buddington, 2003). In their study, Sochodolski et al. (2005) detected 
a wide variability between bacterial microflora counts of dogs housed in an identical 
environment and fed with the same diet and they concluded that individual variability plays 
a major role in the composition of the intestinal microbiota. Mentula et al (2005), in contrast 
with other studies (Greetham et al., 2002; Buddington, 2003) where no bifidobacteria but 
numerous Lactobacillus organisms were reported, found bifidobacteria in 64% but 
lactobacilli only in 32% of the dogs screened. 
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In their study, Simpson et al. (2002) stated that each individual dog harbours a 
characteristic faecal bacterial community which is not influenced by the diet. This statement 
is in opposition to what is reported in others studies in which the authors observed a direct 
influence of diet on bacterial population in the gastrointestinal tract (Zentek, 1995a; Zentek, 
1995b; Vanhoutte et al., 2005; Flickinger et al., 2003). 
 
Table 2.8: Counts of viable bacteria in canine faecal samples (from Simpson et al., 2002). 
Microbial group Counts 
Log CFU/g faeces 
Enterococci 6.91 
Streptococci 8.77 
Staphylococci 3.83 
Bacteroides 10.05 
Fusobacteria 8.67 
Clostridia 6.96 
Bifidobacteria 7.80 
Eubacteria 8.11 
Lactobacilli 9.38 
Total anaerobes 10.62 
Total aerobes 9.28 
Yeast and moulds 2.23 
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3. Diet digestibility 
 
Digestibility values provide information on the relative amounts of nutrients in the 
diet that can be really used by the animal and, additionally, serve as an index of overall 
quality of the ingredients of the diet. 
In order to calculate nutrient digestibility, it is important to quantify the exact amount 
of nutrient consumed by the animal and the amount that is excreted in the faeces. The 
difference between these two quantities, divided by the amount consumed, represents the 
quantity that has been digested. The digestibility coefficient that is obtained with this 
method is an “apparent” rather than a “true” value. In fact, faeces contain a variable quantity 
of nutrients of non-dietary origin such as enzymes, pancreatic juice, bile, mucus, sloughed 
intestinal cells, and bacteria (Phillipson, 1971). Several studies have been conducted to 
quantify endogenous secretions using nitrogen-free diets or diets containing only low 
amounts of a highly digestible protein (e.g. casein), or feeding graded levels of a nutrient 
with extrapolation to zero intake (Hendriks et al., 2002; Kendall et al., 1982). 
Average digestibility coefficients in dogs reported in literature are shown in Table 3.1. 
Values are means calculated on the basis of values reported by Vhile et al., 2007; Guevara 
et al., 2008; Kempe et al., 2007; Yamba et al., 2006; Dust et al., 2005. 
 
Table 3.1: Average digestibility coefficients in dogs reported in literature (Vhile et al., 
2007; Guevara et al., 2008; Kempe et al., 2007; Yamba et al., 2006; Dust et al., 2005) 
 Digestibility coefficients 
Dry matter 82.3 ± 5.17 
Crude protein 82.2 ± 4.50 
Ether extract 92.8 ± 2.60 
Starch 98.6 ± 2.24 
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3.1 Methods to evaluate diet digestibility 
 
Diet digestibility can be evaluated using various methods. The use of metabolic cages, 
which allows a complete collection of excreta, is the oldest technique developed. However, 
housing in cages may influence digestive processes of the animals and the results obtained 
may  be different when animals are kept in a normal environment (Sales & Janssens, 2003). 
The use of indigestible markers is an established method for determining digestibility 
without total collection of faeces. An inert marker must satisfy several criteria; it must be 
indigestible and show only little or no interaction at all with the digestive process. 
Furthermore, homogenous incorporation of the marker in the feed should be possible and 
the marker should be harmless to experimental animals, people who work with the 
substance and the environment (Sales & Janssens, 2003). Indigestible markers that are 
commonly used in digestibility studies include chromic oxide (Cr2O3) (Zuo et al., 1996; 
Hendriks & Sritharan, 2002; Guevara et al., 2008), yttrium oxide (Y2O3) (Vhile et al., 2007) 
or insoluble ash (celite) (Scott & Boldaji, 1997). 
Nowadays, in vitro digestion techniques are gaining interest because in vivo 
determinations are both time consuming (about three weeks are required for the trial and 
analysis of the samples) and expensive (due to the cost of the dogs, the diets, the kennels 
and the labour). Furthermore, in Europe, the use of dogs as experimental animals is a source 
of great concern for most pet owners (and pet-food producers generally avoid to be involved 
in in vivo trials with dogs). Tonglet et al. (2001) tried to correlate in vivo and in vitro protein 
digestibility data obtained using the three-enzymes procedure described by Dufour-Etienne 
et al. (1992). They analyzed seventeen dry complete industrial dog foods and obtained a 
correlation coefficient (r2) of 0.71 between in vitro and in vivo protein digestibility. r2 
represent the fraction of the variance between two parameters that is “shared”, and a value 
close to one describe two parameters that vary together. In this study digestibility 
coefficients determined in vitro explained only a 71% of the variation of  in vivo ones. In a 
recent study, Hervera et al. (2007) tried to develop a simple and reproducible in vitro 
method for predicting the apparent energy digestibility of dry extruded dog foods. Their 
method was based on the two step multy-enzymatic incubation assay described by Boisen 
(1991). They analyzed 54 dry extruded commercial dog foods and obtained a coefficient of 
correlation (r2) of 0.92 between in vitro and in vivo organic matter disappearance. This 
degree of correlation indicates that the proposed method could be effectively used to predict 
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in vivo protein digestibility with an in vitro system; however, other feed components are not 
considered using this technique. 
 
3.2 Factors affecting diet digestibility 
 
Many factors can affect diet digestibility, such as ingredient sources, absolute nutrient 
concentrations, and food processing. In a recent study, Zentek et al. (2004) investigated the 
effect of two different dietary protein sources (beef and poultry), included either in an 
extruded or a canned mixed diet, fed to dogs. Poultry-based and extruded diets were 
associated to higher digestibility coefficients than the beef-based and canned ones. Thermal 
processes are known to improve starch digestibility, in particular extrusion (Perez-Navarrete 
et al., 2007; Murray et al., 2001). In dry extruded pet foods cereal grains are a commonly 
used ingredient because there is a stable supply and are a relatively inexpensive source of 
nutrients. Dogs diets may contain up to 50% starch, derived from cereal grains (almost 60% 
in dry diets). Therefore, the thermal treatment could notably affect diet digestibility. In 
addition, also animal factors must be considered when evaluating digestibility. These 
include breed, age, gender, activity level, and physiological state. With regard to the effects 
of breed, Weber et al. (2003) evaluated the effects of age and body size on the apparent 
digestibility of a dry expanded diet. Four breeds of different body size were used (miniature 
poodles, medium schnauzers, giant schnauzers, great danes) and digestibility experiments 
were conducted at four ages (11, 21, 35 and 60 weeks). Nutrient digestibility was 
significantly higher in large dogs at each age, even though these dogs had lower faecal 
scores and increased faecal moisture concentrations. 
Age too is a factor impacting nutrient digestibility. In the study by Weber et al. 
(2003), macronutrient digestibility increased significantly with age in all four dog breeds. A 
similar finding was reported by Swanson et al. (2004), in a study conducted with senior and 
weanling dogs to determine the effects of age and diet on nutrient digestibility.  
Ahlstrøm et al. (2006) investigated the effect of moderate exercise or low activity on 
nutrient digestibility in trained hunting dogs. Digestibility values were similar in the high 
and low activity periods for all the nutrients. 
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4. Probiotics 
 
A probiotic was defined by Fuller (1989) as a “live microbial food supplement which 
beneficially affects the host by improving the intestinal microbial balance”. The most 
studied probiotics belong to the genera lactobacilli and bifidobacteria, although bacteria 
belonging to other genera (e.g. enterococci) have also been used. Recently, there has been a 
move towards the use of probiotics in the petfood market, where animal wellbeing is a 
major concern. 
Based on the definition of probiotics stated above, it is clear that adequate numbers of 
viable organisms must reach the intestinal tract. For this to happen, probiotic organisms 
must be able to survive transit through the acidic environment of the stomach and resist 
digestion by bile. Potential probiotics must possess a variety of other properties, including 
the ability to adhere to intestinal epithelial cells (or mucus), colonize the intestinal tract, 
produce antimicrobial factors, and inhibit enteric pathogens (Gibson & Fuller, 2000). Other 
properties, such as immunomodulation (Sauter et al., 2006 e 2005) and modulation of 
metabolic activities (Strompfová et al., 2006) are also desirable. An organism can only be 
considered to be a probiotic after these properties have been identified and a positive health 
effect has been documented. 
One important criterion for the selection of a probiotic is host species specificity, 
which is regarded as a prerequisite for showing the beneficial characteristics of the probiotic 
(Fuller, 1989). However, most of the commercial probiotic strains for dogs do not have a 
canine origin. In a recent study, Rinkinen et al. (2003b) utilized an in vitro mucus adhesion 
model to demonstrate that lactic acid bacteria mucus adhesion properties are not host 
specific but rather are characteristic to bacterial specie. A similar finding was reported by 
Lauková et al. (2004), who tested the adhesion properties of two Enterococcus strains to 
human, porcine, and canine mucus.  
Many canine probiotic products contain Enterococcus faecium, whose safety has been 
questioned due to its antibiotic resistance genes and pathogenic characteristics (Strompfová 
et al., 2004; Rinkinen et al., 2003a). Interest in probiotic strains has led to recent cultural 
studies directed towards the isolation of lactobacilli from dog faeces. Perelmuter et al. 
(2008, in press) isolated a Lactobacillus murinus strain from dog faeces and evaluated its 
possible use as probiotic for dogs with in vitro trials. The isolated strain demonstrated 
probiotic properties. In fact, it was able to survive to different pH and bile salts conditions, 
to adhere to intestinal mucus and to inhibit the in vitro growth of E. coli and C. perfringens. 
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In another study, McCoy & Gilliland (2007) compared several Lactobacillus specie in order 
to evaluate their possible use as probiotics. Their study showed that Lactobacillus reuteri 
could be used as a probiotic for dogs. Similar studies were performed by other researchers 
(Manninen et al ., 2006; Beasley et al., 2006; Strompfová et al., 2006; Strompfová et al., 
2004) and led to the identification of various lactic acid bacteria of canine origin that could 
be used as probiotics in dogs. 
 
4.1 Beneficial documented health effects of probiotics in dogs  
 
Appealing properties of probiotics include their ability to reduce antibiotic use, the 
apparently high index of safety, and the public positive perception about “natural” or 
“alternative” therapies. Probiotics are classified, and generally regarded as safe, as opposed 
to antibiotics, which have a number of recognized adverse effects. 
Competitive exclusion of pathogens in the gastrointestinal tract is thought to be one of 
the most important beneficial mechanisms of probiotic bacteria. Competitive exclusion by 
intestinal bacteria is based on bacteria-to-bacteria interaction mediated by competition for 
available nutrients and mucosal adhesion sites. In order to gain a competitive advantage, 
bacteria can also modify their environment to make it less suitable for their competitors. The 
production of antimicrobial substances, such as lactic acid or bacteriocins, is one example of 
this kind of environmental modification (Fooks & Gibson, 2002). 
The possible effects of lactic acid bacteria on dogs’ health have not been extensively 
examined, although some lactic acid bacteria strains have been documented to have 
beneficial effects on the health of dogs. Pasupathy and co-workers (2001) evaluated the 
effect of a Lactobacillus acidophilus strain supplementation on food digestibility and 
growth parameters of puppies. They concluded that the supplementation had a positive 
effect during the active growth phase, although differences between the control group and 
the treated one were not significant. In a later work, Benyacoub et al. (2003) demonstrated 
that dietary supplementation of the diet of puppies with Enterococcus faecium enhanced 
specific immune function. 
Probiotic lactic acid bacteria were also tested to verify their ability to improve health 
status of dogs with gastrointestinal diseases. Sauter et al. (2006) tested the beneficial effect 
of a probiotic cocktail administered to dogs with food responsive diarrhoea. At the end of 
the trial, all the dogs receiving the probiotic supplementation clinically improved. In a 
previous work, Strompfová et al. (2004) detected a reduction in the level of serum 
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cholesterol and alanine aminotranferase after oral administration of a Lactobacillus strain to 
dogs suffering from diseases of the gastrointestinal tract. 
Several researchers investigated the effects of the administration of a probiotic strain 
on the composition of dog intestinal microbiota. The administration of Enterococcus 
faecium significantly decreased Sthaphylococcus spp., Pseudomonas-like bacteria 
(Marcinaková et al., 2006) and Clostridium spp. (Vahjen & Männer, 2003), while it 
increased Salmonella spp. and Campylobacter spp. counts (Vahjen & Männer, 2003) in 
dogs faeces. Sauter et al. (2006) evaluated the effects of a probiotic cocktail containing 
three different Lactobacillus spp. strains on the intestinal microbiota of dogs with food 
responsive diarrhoea. They detected, during the treatment, a decrease in numbers of 
Enterobacteriaceae and an increase in numbers of Lactobacillus spp.. 
 
4.2 Probiotics in pet foods 
 
Nowadays, the pet market offers several probiotic products for use in dogs. They are 
available in tablet, capsule, paste, and liquid form. Some commercial dog foods also claim 
to contain probiotics.  
Biourge et al. (1998) evaluated the feasibility of including a probiotic strain in dry dog 
food during the different phases of the productive process (before and after extrusion) and 
its stability in the final product. A probiotic preparation (spores of Bacillus CIP 5832) was 
added to the meal of a commercial diet before expansion-extrusion or to a powder that was 
coated on the diet after extrusion and drying. As expected, the extrusion process resulted in 
the loss of more than 99% of the bacteria added, while the second technique determined 
losses of about 45% of the added dose. After 12 months of storage, diets prepared with the 
second technique had lost less than 25% of spores. These studies confirmed that the 
addiction of a probiotic strain to a dry dog food is feasible and that it has to be added after 
the extrusion process at a higher concentration than the desired one. 
Rules regarding probiotic supplementation to animals diets are still missing. In a study 
by Weese & Arroyo (2003), who evaluated several commercial foods for dogs that claimed 
to contain probiotics, 26% of the products did not contain any relevant bacterial population 
(among the ones specified in the label), none of the tested products contained all claimed 
strains and 58% of the tested diets contained additional, related bacteria that were not stated 
in the label.  
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5. Prebiotics 
 
A prebiotic is "a non digestible food ingredient that beneficially affects the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria in 
the colon, and thus improves host health”, as it was first defined by Gibson & Roberfroid 
(1995).  
Since its introduction, the concept of prebiotic has attracted much attention. However, 
many food components have been claimed to exert prebiotic activity without any 
consideration to the criteria required. In fact, not all dietary carbohydrates are prebiotics. To 
be classified as a prebiotic a food component has to respect some criteria, such as: 
1. resistance to digestion  
2. fermentation by intestinal microflora 
3. selective stimulation of the growth and/or activity of those intestinal bacteria 
that contribute to health and well-being. 
Recently, the beneficial effects of prebiotics have gained interest also in companion 
animals. Still, little is known at present about the effect that prebiotics can have in the 
intestine of carnivorous animals. 
Targets for prebiotic effects include the colonic microflora, gastrointestinal 
physiology, immune function, bioavailability of minerals, lipid metabolism and 
gastrointestinal tract health (Roberfroid, 1999).  
The main classes of dietary carbohydrates and their physiological characteristics are 
reported in Table 5.1 and 5.2, respectively. 
Table 5.1: Principal physiological characteristics of dietary carbohydrates (Cummings & 
Stephen, 2007). 
 
Provide 
energy  
Increase 
satiety  
Cholesterol 
lowering  
Increase 
calcium 
absorption  
Source 
of 
SCFA  
Alter 
balance of 
microflora 
(prebiotic)  
Increase 
stool 
output  
Immunomodulatory  
Monosaccharides √        
Disaccharides √   √     
Polyols √    √  √  
Maltodextrins √        
Oligosaccharides 
(non-α-glucan) √   √ √ √  √ 
Starch √    √  √  
NSP √ √ √  √  √  
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Table 5.2: Classification of dietary carbohydrates by molecular size (Cummings & 
Stephen, 2007) 
Class (DP a) Subgroup Principal components 
Monosaccharides Glucose, fructose, galactose 
Disaccharides Sucrose, lactose, maltose, trehalose Sugars (1–2) 
Polyols (sugar alcohols) Sorbitol, mannitol, lactitol, xylitol, 
erythritol, isomalt, maltitol 
Malto-oligosaccharides 
(α-glucans) Maltodextrins Oligosaccharides (3–9) 
(short-chain carbohydrates) Non-α-glucan 
oligosaccharides 
Raffinose, stachyose, fructo and 
galacto oligosaccharides, polydextrose, 
inulin 
Starch (α-glucans) Amylose, amylopectin, modified 
starches 
Polysaccharides (≥10) 
Non-starch 
polysaccharides (NSPs) 
Cellulose, hemicellulose, pectin, 
arabinoxylans, β-glucan, 
glucomannans, plant gums and 
mucilages, hydrocolloids 
a
 Degree of polymerization or number of monomeric unit. 
 
Prebiotic carbohydrates are important because of the new concept of a healthy or 
balanced gut flora. A healthy, or ‘balanced’ microbiota is one that is predominantly 
saccharolytic and comprises significant numbers of bifidobacteria and lactobacilli 
(Cummings et al., 2004). This concept is based on a number of observations. The genera 
Bifidobacterium and Lactobacillus do not contain any known pathogens, and they are 
primarily carbohydrate-fermenting bacteria, unlike other groups such as Bacteroides and 
clostridia that are also proteolytic and amino-acid fermenting. The products of carbohydrate 
fermentation, principally SCFAs are beneficial to host health, while those of protein 
breakdown and amino acid fermentation, which include ammonia, phenols, indoles, thiols, 
amines and sulphides, are not (Cummings & Macfarlane, 1991). Furthermore, lactic acid-
producing bacteria such as bifidobacteria and lactobacilli play a significant role in the 
maintenance of colonization resistance, through a variety of mechanisms (Gibson et al., 
2005).  
Almost any carbohydrate that reaches the large bowel will provide a substrate for the 
commensal microbiota, and will affect its growth and metabolic activities. This has been 
shown for non-starch-polysaccharides (Stephen & Cummings, 1980), and will occur with 
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other substrates such as resistant starch, sugar alcohols and lactose. However, stimulation of 
growth by these carbohydrates is a non specific, generalized effect, that probably involves 
many of the major saccharolytic groups in the large bowel (Macfarlane & Cummings, 
1991). The selective properties of prebiotics relate to the growth of bifidobacteria and 
lactobacilli at the expense of other groups of bacteria in the gut, such as Bacteroides, 
clostridia, eubacteria, enterobacteria, enterococci, and so on. 
 
5.1 Effects of prebiotics on the microbial population of small and large 
intestine. 
 
Few studies have been conducted to evaluate the effects of prebiotics on bacteria in 
the small intestine of companion animals. Willard et al. (2000) evaluated the effect of the 
dietary supplementation with fructooligosaccharides (FOS) at a concentration of 1% to 
healthy dogs. In their study, FOS supplementation did not have a significant effect on faecal 
concentration of bacteria. The researchers hypothesized  that the lack of effect of FOS on 
faecal bacterial populations might depend on the wide variation among individual dogs. In a 
study by Swanson et al. (2002b), FOS did not affect dog faecal bacterial counts when 
administered at a concentration of 0.5%, but the same authors reported a significant increase 
in faecal lactobacilli and bifidobacteria after the administration of FOS (1%) plus 
mannanooligosaccharides (MOS; 0.5%) (Swanson et al., 2002c) and FOS alone (1.3%; 
Swanson et al., 2002a). In another study, Flickinger et al. (2003) evaluated the effects in 
dogs of the dietary supplementation with FOS at four concentration levels (0, 0.3, 0.6, and 
0.9%). At these concentrations, FOS did not affect lactobacilli and bifidobacteria counts but 
significantly decreased C. perfringens. In a previous study, supplemental FOS (1%) 
determined a significant increase in the number of faecal bifidobacteria, streptococci 
andclostridia (Beynen et al., 1998). 
Grieshop et al. (2004) evaluated the effects of chicory (a natural source of inulin) at 
1%  , alone or together with MOS, in senior dogs. In their study, chicory determined a 
significant increase in faecal bifidobacteria concentration compared to the control group. In 
another study (Zentek et al., 2003), administration of chicory, supplemented at 3%, did not 
affect bifidobacteria faecal concentration. 
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5.2 Effects of prebiotics on the intestinal mucosa 
 
Prebiotics are fermented in the colon to SCFAs. Short-chain fatty acids (butyrate, 
acetate,  propionate, and lactate) are associated with a trophic effect on the colonic 
epithelium (Blottière et al., 2003). Propst et al. (2003) detected a significant increase of 
faecal acetate, propionate and butyrate in dogs fed inulin and oligofructose at three 
concentrations (0.3, 0.6, and 0.9%). A similar finding was reported by Vickers et al. (2001), 
who detected a higher production of all the SCFAs analyzed in in vitro fermentation 
systems containing inulin and FOS compared to fermentors containing cellulose. When 
fermented in vitro with dog faecal inoculum, several prebiotics (FOS, citrus pectin, 
lactulose, guar gum) rapidly produced an increase of the concentration of SCFAs (Sunvold 
et al., 1995). 
 
5.3 Protein catabolism and production of putrefactive agents 
 
Fermentation of undigested amino acids and endogenous protein determines the 
production of several putrefactive compounds. These compounds include ammonia, 
aliphatic amines, branched-chain fatty acids (BCFA), indoles, phenols, and volatile sulphur-
containing compounds (MacFarlane & Cummings, 1991). 
When administered to dogs at a concentration of 1.3%, FOS determined a significant 
decrease in fecal ammonia, isobutyrate, isovalerate, and total branched-chain fatty acid 
concentrations (Swanson et al., 2002a); when fed at 0.5%, FOS decreased faecal indole and 
phenol concentrations (Swanson et al., 2002b). On the contrary, in the study conducted by 
Flickinger et al. (2003), FOS administered at 0.3, 0.6, and 0.9% did not affect BCFA, 
ammonia, phenols, and indoles concentrations.  
 
5.4 Effects of prebiotics on nutrient digestibility 
 
A few studies investigated the effect of prebiotics on nutrient digestibility. In  a study 
by MIddelbos et al. (2007), the addition of FOS (1.2% and 1.5%) to a dog diet caused a 
significant reduction of protein digestibility. Similar findings were reported by Verlinder et 
al. (2006) after the addition of inulin at 3%, Propst et al. (2003) after the addition of inulin 
and oligofructose at 0.3, 0.6, and 0.9%, and Hesta et al. (2003) after supplementation with 
FOS and isomalto-oligosaccharides (3%). In the study by Hesta et al. (2003),when nitrogen 
 21 
digestibility was corrected for bacterial nitrogen, the differences between the control and 
oligosaccharide-supplemented groups disappeared. This indicates that the lower total tract 
nitrogen digestibility was not a consequence of a lower small intestinal digestibility but the 
result of a higher faecal content of nitrogen originating from bacteria grown in the large 
intestine. 
 
5.4 Effects of prebiotic on mineral methabolism 
 
Prebiotic are known to increase the absorption of several minerals (calcium, 
magnesium, and phosphorus) and trace elements (mainly copper, iron, and zinc). The 
stimulation of absorption seems to be more pronounced in deficient animals. Few data are 
reported in literature about mineral absorption in dogs after prebiotic administration. 
Beynen et al. (2002, 2001) evaluated the effect of the administration of oligofructose (1%) 
and lactulose (1 or 3 grams/MJ metabolizable energy) on mineral absorption in dogs. 
Oligofructose determined a rise of calcium and magnesium absorption, and the same was 
detected with lactulose.  
 
5.5 Systemic effects of prebiotics 
 
Some authors investigated the effects of prebiotics on plasma metabolite 
concentrations of dogs. Diez et al. (1998) measured plasma glucose and insulin 
concentrations in response to supplemental (7%) inulin, guar gum, or sugar beet fiber in dog 
diets. The investigators determined that guar gum induced lower postprandial insulin, alpha-
amino-nitrogen and urea plasma concentrations and fasting cholesterolaemia, while sugar-
beet fibre and inulin showed no metabolic effects. In a previous work, the same authors 
(Diez et al., 1997) detected a significant decrease in postprandial glucose, urea and 
triglyceride concentrations and preprandial glucose, urea and cholesterol after the 
administration of a blend of inulin and sugar beet fiber (4:1) when inulin reached the 
concentration of 4 and 8%. 
Several authors have proved the ability of prebiotics to modulate immune function in 
humans and laboratory animals (Seifert & Watzl, 2007; Vos et al., 2007). Adogony et al. 
(2007) tested the ability of short-chain FOS, administered to female dogs, to enhance the 
mucosal immunoglobulin level in mammary secretions. Results from their study showed 
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that dogs supplemented with scFOS exhibited higher colostrum and milk IgM content 
without concomitant effect on IgG1, IgG2 and IgA. 
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Aim of the thesis 
 
Aims of the present study were: 
• Development of a simple and reproducible in vitro method for predicting the 
digestibility of pet-food. 
• Isolation of a Lactobacillus strain from dogs faeces and examination of its 
potentially probiotic properties . 
• Investigation of the effects of several non-digestible oligosaccharides on dog 
intestinal microflora composition and metabolism.  
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6. Digestibility study: Material and methods 
6.1 Development of the in vitro digestion technique 
 
6.1.1 Feed samples 
 
Nine samples of different commercial pet foods (dry and wet) were used. Analyses of 
the diets (crude protein, crude fibre, ether extract, ash, and starch) were performed according 
to AOAC standard methods (AOAC, 2000). Table 6.1 shows the chemical composition of 
the diets. 
 
Table 6.1: Chemical composition (on dry matter basis) of the diets used during the 
development of the in vitro digestion technique. 
Pet-food Crude protein Ether extract Starch Crude fibre Ash 
1 (dry, cat) 32.91 11.57 42.21 1.77 7.28 
2 (dry, cat) 29.85 12.97 37.92 2.47 7.25 
3 (dry, cat) 37.72 16.96 35.46 1.13 6.96 
4 (wet, cat) 31.75 22.62 29.16 0.79 8.65 
5 (dry, dog) 31.75 16.00 39.06 1.60 6.96 
6 (dry, dog) 30.84 15.49 43.20 1.18 6.57 
7 (dry, dog) 26.72 11.19 39.24 3.43 8.92 
8 (wet, dog) 31.70 23.50  1.56 8.64 
9 (wet, dog) 35.68 30.27 19.26 0.96 11.48 
 
6.1.2 In vitro digestion 
 
Samples of pet foods were first digested using the in vitro digestion technique 
proposed by Vervaeke et al. (1989). The method can be briefly summarized as follows: 
1. Sample preparation: samples of pet food were dried at 65°C overnight and finely 
ground (< 1 mm particle size). 
2. Step 1 (gastric digestion simulation): For each pet food sample, 400 mL of a 0.2% 
pepsin solution (HCl 0.075N; Pepsin from porcine gastric mucosa, 600-1,800 
units/mg, P7125, Sigma-Aldrich) were added in a 1 L bottle to 20 g of pet 
food. Bottles were incubated in a shaking waterbath at 39°C for 4 hours. 
3. Step 2 (small intestinal digestion simulation): pH level was adjusted to 7.5 with 
NaOH (1 N)and 400 mL of a pancreatin solution (1% in phosphate buffer; 
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Pancreatin from porcine pancreas, P1500, Sigma-Aldrich) were added. 
Bottles were incubated in a shaking waterbath at 39°C for 4 hours. 
4. Centrifugation: after the enzymatic digestion, the content of each bottle was 
centrifuged (3,000 x g, 10 min, 4°C), washed twice with distilled water, re-
centrifuged (3,000 x g, 5 min, 4°C), and the residue is dried at 65°C 
overnight. 
 
Phosphate buffer was prepared mixing three solutions: 
• Solution 1 (g/L):  
o 48.44 g of Na2HPO4 
o 49.0 g NaHCO3 
o 2.35 g of NaCl 
o 2.85 g of KCl 
• Solution 2 (g/L):  
o 60 g of MgCl2 
• Solution 3 (g/L):  
o 12.89 g MgCl2•6 H2O 
• 500 mL of solution 1, 5 mL of solution 2 and 5 mL of solution 3 were mixed, and 
the volume was adjusted to 1 L adding distilled water. Final pH was adjusted to 
7.5 with HCl 1 N. 
 
6.2.3 Calculation and data analysis  
 
In order to determine diet digestibility, the residue obtained from each bottle after the 
in vitro digestion was weighed and digestibility was calculated with the following equation: 
 
100 – [ (residue weight x 100) / sample weight ] 
 
The un-digested fraction was then analysed for crude protein, ether extract, crude 
fibre, starch and ash, according to AOAC standard methods (AOAC, 2000). Nutrient 
digestibility was calculated with the following equation: 
 
100 – {[nutrient percentage in residue x (100 – diet digestibility)] / nutrient percentage 
in diet} 
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Digestibility data obtained with the in vitro technique were compared to digestibility 
data from the literature (obtained from in vivo trials). Because digestibility coefficients 
obtained with the in vitro method proposed by Vervaeke et al. (1989) differed from those 
that are reported in the literature, particularly the results regarding digestibility of lipids (see 
Table 3.1, Table 7.1), the method proposed by Vervaeke et al. (1989) was modified, in order 
to develop a new method that could better represent the peculiar digestive physiology of 
dogs and cats. In particular, the following critical points were considered during the study: 
• Food sample and digestive solution ratio; 
• Addition of lipase and/or emulsifiers to the digestive solutions; 
• Pancreatin concentration in the second phase solution; 
• Duration of each digestion phase (gastric and intestinal); 
• Food characteristics (dry, wet, for dog, for cat). 
 
After several in vitro digestion trials, the following new method was developed. 
 
1. Sample preparation: each pet foodsample is dried at 65°C overnight and finely 
ground (< 1 mm particle size). 
2. Step 1 (gastric digestion simulation): 10 g of pet food sample are added with 400 
mL of a 0.2% pepsin solution (HCl 0.075N;) containing 0.1% gastric lipase 
(Rhizopus lipase, F-AP15, Amano Enzyme Inc.). and incubated in a 1 L 
bottle in a shaking waterbath at 39°C for 2 hours. 
3. Step 2 (small intestinal digestion simulation): pH level is adjusted to 7.5 with 
NaOH (1 N). Then, 400 mL of a 1% pancreatin solution in phosphate buffer 
(prepared as described before) are added to each bottle. Immediately prior to 
addition of the pancreatin solution, bile salts (Cholic acid-Deoxycholic acid 
sodium salt mixture, 48305, Fluka) are added to each bottle at the final 
concentration of 2.5%. The bottle is placed again in the shaking waterbath at 
39°C for 4 hours. 
4. Centrifugation: after enzymatic digestion, the preparation is centrifuged (3,000 x g, 
10 min, 4°C), washed twice with distilled water, re-centrifuged (3,000 x g, 5 
min, 4°C), and the residue is dried at 65°C overnight. 
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6.2 Validation of the new in vitro method  
 
In order to validate the new in vitro method, an in vivo digestibility study with dogs 
was performed. Three dry extruded diets for dogs were digested both in vitro and in vivo. 
 
6.2.1 Animals 
 
A total of 18 dogs (different breeds, same environment, with an average body weight 
of 24.9 ± 6.39 kg) were used for the in vivo digestibility trial. Before the beginning of the 
trial, all dogs were screened for intestinal parasites and infected ones were treated 
(DRONTAL, Bayer S.p.A). Dogs were randomly assigned to three different diets (six 
animals for each group) and individually housed in boxes. After a 5-day adaptation period 
(during which dogs were progressively adapted to the experimental diets), dogs received for 
12 days the experimental diets. . During the last 5 days, all faeces excreted by each dog 
were collected, weighed and immediately frozen. Dogs were fed once daily according to 
their maintenance energy requirement, had free access to water and were allowed daily 
exercise outside of their boxes.  
 
6.2.2 Diets 
Three dry extruded diets were evaluated in this study. Celite, a source of acid-
insoluble ash, was used as a digestion marker at 1.5% of the diet. Chemical analysis of the 
dietary treatments are presented in Table 6.2.  
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Table 6.2: Chemical analysis of diets used in in vivo trial (percentage on dry matter basis). 
 T1 T2 T3 
Dry matter 94.50 93.73 94.86 
Crude protein 23.81 24.81 23.97 
Ether extract 16.41 18.35 15.47 
Crude fibre 2.36 1.65 2.57 
NDF 17.59 12.66 18.21 
ADF 9.11 7.85 10.59 
ADL 3.54 3.21 2.83 
Ash 9.67 8.80 9.47 
Insoluble ash 1.78 1.59 1.28 
Starch 29.97 34.57 34.74 
NDF: Neutral Detergent Fibre; ADF: Acid Detergent Fibre; ADL Acid Detergent Lignin 
 
6.2.3 Samples analyses 
 
The frozen faecal samples from every single dog were freeze-dried, finely ground (< 1 
mm particle size), mixed and analysed (crude protein, crude fibre, ether extract, starch, ash 
and insoluble ash) according to AOAC standard methods (AOAC, 2000). All samples were 
analyzed in duplicate.  
 
6.2.4 Calculation and data analysis  
 
Diet and nutrients digestibility was calculated as previously described.  
 
In order to compare in vivo and in vitro digestibility data, the same three diets were 
digested using the new in vitro method (see chapter 6.1.2). Each diet was digested in 
triplicate. Analyses (crude protein, crude fibre, ether extract, starch, ash and insoluble ash) 
of the un-digested residue were performed according to AOAC standard methods (AOAC, 
2000). All samples were analyzed in duplicate. 
Linear regression was used to determine the precision and accuracy of the established 
relationship between in vivo and in vitro data.  
 29 
7. Digestibility study: Results  
 
7.1 Development of the in vitro digestion technique 
 
7.1.1 Method proposed by Vervaeke et al. (1989) 
 
The results obtained with the method proposed by Vervaeke et al. (1989) are shown in 
Table 7.1. The chemical composition of the tested pet-foods is shown in Table 6.1. 
 
Table 7.1: Digestibility (Mean ± SEM) of different dry pet-foods determined with the 
method proposed by Vervaeke et al. (1989)..  
Pet-food  Digestibility 
 N Dry matter Crude protein Ether extract Starch 
1 3 72.9 ± 0.54 87.5 ± 0.63 32.5 ± 4.53 94.7 ± 0.49 
2 3 72.2 ± 0.18 85.1 ± 0.37 41.6 ± 0.75 96.1 ± 0.26 
3 3 73.5 ± 0.40 79.9 ± 0.26 52.3 ± 0.77 95.5 ± 0.21 
5 3 72.4 ± 0.42 84.7 ± 1.00 28.9 ± 1.05 96.3 ± 0.19 
6 3 73.2 ± 0.31 79.2 ± 0.23 45.3 ± 1.32 95.6 ± 0.24 
7 3 65.7 ± 0.39 83.1 ± 0.58 33.8 ± 1.31 96.6 ± 0.16 
Literaturea 50 82.3 ± 5.17 82.2 ± 4.50 92.8 ± 2.60 98.6 ± 2.24 
a
 Means obtained from: Vhile et al., 2007; Guevara et al., 2008; Kempe et al., 2007; Yamba et al., 
2006; Dust et al., 2005. 
 
 
7.1.2 Effect of the food / digestive solution ration food digestibility 
 
The ratio between food and digestive solutions in the method proposed by Vervaeke et 
al. (1989) is 1:40 (see procedure described in chapter 6.1.2). Because this ratio influences 
the quantity of enzymes that are available to digest the substrate, different food / digestive 
solution ratios (1:20, 1:40, and 1:80) were tested (Table 7.2). 
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Table 7.2: Dry matter digestibility (Mean ± SEM) using different food/digestive solutions 
ratios (1:20, 1:40, and 1:80). 
Ratio N Digestibility (%) 
1:20 3 66.5 ± 5.79 
1:40 3 70.9 ± 3.79 
1:80 3 75.3 ± 2.31 
 
It was decided to further use the 1:80 food to solution ratio, because this ratio  lead to 
lipid digestibility values that were closer to those reported in literature. 
 
7.1.3 Addition of lipase and emulsifiers 
 
In order to further improve lipid digestion, gastric lipase and emulsifiers were added 
to the digestive solutions.  
The addition of gastric lipase (Rhizopus lipase, F-AP15, Amano Enzyme Inc., Japan) 
at different concentrations to the pepsin-HCL solution was tested in combination with the 
addition of a non-ionic surfactant (Tween 20, Polyoxyethylene sorbitan monolaurate) or bile 
salts (Cholic acid-Deoxycholic acid sodium salt mixture, 48305 Fluka) to the pancreatin 
solution (Figure 7.1). 
The addition of gastric lipase (0.1 and 0.4%) and bile salts at the final concentration of 
2% improved lipid digestibility and the data that were obtained were more consistent with 
data reported in literature.  
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Figure 7.1: Ether extract digestibility obtained using different digestive solutions compared 
with results reported in literature a (dotted line indicates literature resultsa, solid line 
indicates results obtained with the technique proposed by Vervaeke et al., 1989). 
Legend:  
• Tw20: Tween 20 
• L: Lipase 
• BS: Bile salts 
a
 Means obtained from: Vhile et al., 2007; Guevara et al., 2008; Kempe et al., 2007; Yamba et al., 
2006; Dust et al., 2005. 
 
 
7.1.4 Pancreatin concentration 
 
We also considered the effects of different pancreatin concentrations in the second 
phase digestive solution.. 
Two different pancreatin concentrations were tested using a wet diet for dogs (pet-
food number 9). This diet was chosen for its high fat content in order to verify the 
effectiveness of the method. Table 7.3 shows the results obtained using pancreatin at 1 and 
1.25%.  
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Table 7.3: Dry matter, crude protein, ether extract and starch digestibility obtained using 
pancreatin at 1 and 1.25%. The pet food used in the trial was 9 (wet, dog). Mean ± SEM. 
Bile salts 
(%) 
Pancreatin 
(%) N Digestibility 
   Dry matter Crude protein Ether extract Starch 
2 1 2 84.8 ± 0.28 85.2 ± 0.28 86.0 ± 0.26 * 
2 1.25 2 84.8 ± 0.40 89.3 ± 0.28 85.2 ± 0.39 * 
2.5 1 2 85.3 ± 0.07 87.1 ± 0.06 90.9 ± 0.05 * 
2.5 1.25 2 84.8 ± 0.20 86.7 ± 0.17 89.4 ± 0.14 * 
* Starch present in traces in undigested residue. 
 
Digestibility data obtained with pancreatin at 1.25% did not significantly differ from 
those obtained with 1% addition. 
 
7.1.5 Duration of each digestive phase 
 
Duration of each digestive phase directly affects the time of substrate exposure to 
digestive enzymes. The method proposed by Vervaeke et al. (1989) consisted of two 
digestive phases of 4 h each.  
In order to better represent the digestive physiology of carnivores, it was decided to 
reduce duration of the gastric phase from four to two hours (Table 7.4).  
 
Table 7.4: Dry matter, crude protein, ether extract, and starch digestibilities obtained with 
different combinations of times. Pet foods used in the trial were 1 (dry cat) and 8 (wet dog), which 
composition is shown in Table XX. Data are expressed as Means ± SEM. 
 Phase 
Duration 
(h) 
N Digestibility 
   Dry matter Crude protein Ether extract Starch 
2 + 4 8 86.4 ± 1.46 91.5 ± 1.10 94.9 ± 3.69 * 
D
ry
 
4 + 4 8 84.2 ± 2.20 91.1 94.5 ± 4.26 * 
 
      
2 + 4 5 87.5 ± 0.26 89.2 ± 0.20 87.7 ± 0.82 * 
Wet 
4 + 4 3 89.3 ± 0.34 91.7 ± 0.26 88.4 ± 0.36 * 
* Starch present in traces in undigested residue. 
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Comparing the digestibility results obtained with the two different durations of the 
gastric phase, no significant difference was observed..  
 
Figure 7.2: Comparison of digestibility coefficients reported in literature and obtained 
applying the protocol proposed in the present study. 
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7.2 Correlation of in vitro and in vivo digestibility coefficients 
 
A trial was conducted to compare in vivo digestibility of pet-foods and in vitro 
digestibility using the newly developed method. 
The results obtained from the trial are presented in Table 7.5. Table 7.6 and Figures 
7.3, 7.4 and 7.5 show the characteristics of the regression equations calculated. 
 
 
Table 7.5: Digestibility coefficients of three pet-foods evaluated in vivo and  in vitro (Means 
± SD).  
Digestibility T1 T2 T3 
 in vivo in vitro in vivo in vitro in vivo in vitro 
Dry matter 81.55 ± 0.85 80.65 ± 0.30 76.19 ± 1.09 80.00 ± 0.19 79.73 ± 0.48 80.40 ± 0.12 
Crude Protein 82.59 ± 0.92 83.24 ± 0.86 76.49 ± 1.52 85.52 ± 0.60 81.23 ± 0.89 83.95 ± 1.07 
Ether extract 96.52 ± 0.32 94.61 ± 0.42 95.03 ± 0.64 96.35 ± 0.19 96.73 ± 0.25 93.34 ± 0.55 
Crude Fiber 26.87 ± 7.32  16.82 ± 2.22  24.54 ± 0.76  
Starch * * * * * * 
Crude ash 49.90 ± 3.45  33.60 ± 3.64  52.75 ± 2.14  
*
 Starch present in traces in undigested residue. 
 
 
Table 7.6: Characteristics of regression equations calculated fro Dry mater, Crude 
protein and Ether extract. 
 y: in vivo digestibility coefficient 
 x: in vitro digestibility coefficient 
 
 Dry matter Crude protein Ether extract 
Equation y = 8.30 x – 588.2 y = - 2.57 x + 295.5 y = - 0.57 x + 149.7 
Correlation 
coefficient 0.9976 0.9957 0.9098 
 35 
Figure 7.3: Dry matter digestibility coefficients of three pet-foods evaluated in vivo and  in 
vitro.  
 
Figure 7.4: Crude protein digestibility coefficients of three pet-foods evaluated in vivo and 
in vitro.  
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Figure 7.5: Ether extract digestibility coefficients of three pet-foods evaluated in vivo and in 
vitro.  
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8. Digestibility study: Discussion 
 
8.1 Development of the in vitro digestion technique 
 
Mean total digestibility of pet-foods digested with the method proposed by Vervaeke 
et al. (1989) was far below the digestibility values that are reported in the literature (65-73% 
vs 74-80%). In particular, using the method proposed by Vervaeke et al. (1989), lipid 
digestibility was very low (29-52% vs 76-97%) and seemed to be the factor that affected 
total digestibility. It has to be considered that Vervaeke et al. (1989) proposed their method 
to determine the digestibility of diets for pigs which usually contain much lower 
concentrations of lipids than diets for dogs and cats. In particular, the Vervaeke method 
does not imply the utilization of gastric lipase and bile salts, the latter an essential factor in 
the digestion of lipids. Conversely, protein and starch digestibility data were consistent with 
those reported in literature (Table XX). 
The addition of Tween 20 determined a higher lipid digestibility. These results are 
consistent with data reported by Shome et al. (2007) who detected an increase in lipase 
activity, ranging from 26 to 72%, in presence of non ionic surfactants. However, 
digestibility coefficients obtained were lower than those that are reported in literature. After 
the addition of bile salts and gastric lipase lipid digestibility resulted more consistent with 
data reported in literature. It is known,that one characteristic of digestive lipase is its 
specificity to act on a specific emulsion interface (Armand et al., 1999). The emulsion 
interface properties, namely, droplet size and specific surface area, govern the activity of 
lipase on dietary fat emulsion. Therefore, changes in the emulsion droplet size and surface 
area might have an important role in modifying fat digestion and absorption. Emulsification 
of dietary fats in vivo is accelerated greatly as the chime enters the small intestine and is 
mixed with bile and pancreatic secretion. In the gut, bile salts and phospholipids cooperate 
in the emulsification of dietary triglycerides and other fat soluble nutrients improving the 
activity of lipase. Also in dogs, lipid digestion is increased by the concomitant presence of 
bile salts. In fact, Meyer et al. (1994), in a study conducted in vivo, detected a positive linear 
correlation between lipid digestion and taurocholate molar concentration in dog’s intestine.  
Duration of each digestive phase directly affects the time of exposure of substrate to 
digestive enzymes. Physiological data reported in literature about gastric emptying and 
intestinal transit time in dogs comprise a wide range of times (Wyse et al., 2003). Rates of 
gastric emptying and intestinal transit time are influenced by many factors related both to 
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animal and diet characteristics. In the present trial, reducing the duration of the gastric phase 
lead to digestibility coefficients that were coherent with data reported in literature (Table 
XX).  
 
8.2 Correlation of in vitro and in vivo digestibility coefficients 
 
The results obtained in the present study indicate that in vivo digestibility coefficients 
can be predicted quite accurately using the proposed in vitro method. Correlation 
coefficients showed, for dry matter and crude protein, a close similarity between 
digestibility data obtained with in vivo and in vitro methods (0.9976 and 0.9957, 
respectively). Ether extract presented a lower correlation coefficient, although close to 1 
(0.9098).  
It is well known that the microflora of the digestive tract can affect the nutritional 
status of the host, changing the digestibility and absorbability of nutrients (March, 1979). 
Karr-Lilienthal et al. (2004) estimated that approximately 50% (49.6-51.4%) of the dry 
matter of dog faeces is of bacterial origin. This can significantly affect nutrients content in 
faeces creating a discrepancy between in vivo and in vitro data. In fact, chemical analysis 
are not able to discriminate between nutrients of “faecal” or bacterial origin. Several authors 
(Sunvold et al., 1995; Muir et al., 1996; Flickinger et al., 2000) found evidence of an 
apparent inhibition of nitrogen digestion in vivo when diets containing fermentable fibre 
were administrated. They postulated that this finding was due to increased bacterial 
metabolism associated with the production and excretion of greater quantities of nitrogenous 
constituents. Moreover, we have to consider that not all the components that are solubilised 
in vitro and are considered as digested are really digestible and absorbable in vivo. This 
condition creates a tendency to overestimate digestibility coefficients using in vitro 
enzymatic methods. 
Nevertheless, the aim of this study was to assess the existence of a correlation 
between digestibility coefficients obtained in vivo and in vitro, and to obtain equations 
which relate in vivo digestibility coefficients to in vitro ones. On the basis of collected data, 
the proposed in vitro method provided digestibility coefficients which correlated well with 
in vivo ones.  
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9. Probiotic study: Material and methods 
9.1 Isolation of the probiotic strain 
 
Seventeen healthy adult dogs (household dogs, different breeds, fed different 
commercial dry diets and living in different environments; between 1 and 3 years of age), 
that had followed a pre/probiotic-free diet for 1 month and had not been treated with 
antibiotics for at least 3 months, were screened for faecal LAB and bifidobacteria contents. 
Fresh faeces were collected immediately after excretion in sterile vessels and frozen at –
18°C within 20 min. Within 10 days from collection, faeces were homogenized and serially 
diluted in half-strength Wilkins-Chalgren Anaerobe Broth (WCAB 0.5x, Oxoid LTD, 
Basingstoke, Hampshire, UK) added with L-cysteine HCl (0.5 g/L). Dilutions were plated 
on Raffinose Bifidobacterium Agar (RB Agar; Hartemink et al., 1996) and LAMVAB Agar 
(Hartemink et al., 1997), for bifidobacteria and lactobacilli counts, respectively. Plates were 
incubated in an anaerobic cabinet (Anaerobic System, Forma Scientific Co., Marietta, USA) 
under a N2 85%, CO2 10%, H2 5% atmosphere at 37°C for 48 h (results shown in Table 
10.1). 
Attribution to the genus Bifidobacterium of the colonies isolated on RB agar was 
achieved by assaying fructose-6-phosphate phosphoketolase activity, the key enzyme of 
Bifidobacterium carbohydrate metabolism (Scardovi, 1986). In order to confirm that new 
isolates belonged to this genus, colonies were picked for amplification with the 16S rDNA 
primer set Bif164/Bif662 specific for this genus, according to Kok et al. 1996, to 
identificate the proper 523 bp amplicon.  
Attribution to the specie of RB and LAMVAB colonies was obtained by subculturing 
on MRS. Pure MRS coltures were ribotyped for speciation using the automated ribotyping 
device, RiboPrinter Microbial Characterisation System (Qualicon Inc., Wilmington, DE, 
USA). Bacterial colonies were picked from agar plates, suspended in sample buffer, 
inactivated by heat kill step, and treated with lytic enzymes to release the DNA. The DNA 
was cut with EcoRI and the fragments were electrophoretically separated and 
simultaneously transferred to a nylon membrane. A DNA probe for the Escherichia coli 
rrnB operon was then hybridized to the genomic DNA on the membrane. Each clone was 
identified by comparison of the RiboPrint pattern with an identification database of EcoRI 
RiboPrint patterns created by E. I. DuPont de Nemours and Company (Qualicon Inc.). The 
taxonomic attribution was confirmed by rDNA sequence analysis. The proper primer set 
was used to amplify the ribosomal fragments comprising the Internal Transcribed Spacers 
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(ITS) and the flanking 16S and 23S rDNA regions. The amplified products were separated 
by gel electrophoresis, the fragments of ca 550 bp were purified using a QIAquick Gel 
Extraction Kit (QIAGEN, Hilden, Germany), and then subjected to automated sequence 
analysis of both DNA strands. 
9.2 Preparing of the supplement 
 
After speciation, it was decided to use one of the isolated strains belonging to the 
specie Lactobacillus animalis in a feeding trial with adult dogs for its high biomass yield.  
The L. animalis strain was grown on the following complex medium called CM:  
 
• phytone, 10 g/L (Difco Laboratories, Sparks, USA);  
• casein hydrolisate, 10 g/L;  
• sodium acetate, 2.5 g/L;  
• yeast exctract, 10 g/L (Difco Laboratories, Sparks, USA);  
• Tween 80, 1 g/L;  
• L-cysteine HCl, 0.5 g/L;  
• MnSO4 7H2O, 7 mg/L;  
• KH2PO4, 0.15 g/L;  
• MgSO4 7H2O, 0.5 g/L;  
• pH was adjusted to 6.8. The medium was, then, autoclaved for 30 min at 110°C.  
• Glucose was autoclaved separately and added to the sterile basal medium to obtain 
the final concentration of 20 g/L. 
The Lactobacillus strain was subcultured in Lactobacilli MRS broth (Difco 
Laboratories, Sparks, USA) containing 0.5 g/L L-cysteine HCl and anaerobically incubated 
at 37°C for 24 h.  
Cells from the MRS cultures were inoculated (5% v/v) into CM medium and 
incubated anaerobically at 37°C for 48 h. After the incubation time the biomass was 
harvested by centrifugation and resuspended in preservation Suspending Fluid (skim milk 
50 g/L; lactose 30 g/L; yeast exctract 50 g/L; ascorbic acid, 5 g/L) for the lyophilization 
process.  
The freeze-dried probiotic product contained about 109 CFU/g. 
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9.3 In vitro trial 
 
In order to prepare faecal cultures, fresh faecal samples (from two adult healthy dogs) 
were suspended 1% (w/v) in pre-reduced WCAB 0.5x. Faecal suspension was added (1% 
v/v) to 100 mL anaerobic serum bottles containing 80 ml of Faecal Extract Medium. Faecal 
Extract Medium was obtained following the procedure described by Benno and Mitsuoka 
(1992) using fresh faeces collected from 15 adult healthy dogs. Faecal cultures were 
inoculated (1% v/v) with the freeze-dried L. animalis strain resuspended in WCAB medium 
at a concentration of 108 CFU/mL (in order to achieve in the faecal cultures a final L. 
animalis concentration of 106 CFU/mL) or, as a negative control, with the same volume of 
sterile WCAB medium. Each bottle received the addition of 1 g of in vitro digested dry food 
for adult dogs (Table 9.1) suspended in 10 mL of physiological solution. The in vitro 
digested food simulates the undigested fraction of the diet that reaches the hindgut and is 
obtained by in vitro digestion (2 h incubation with HCl + gastric lipase + pepsin followed by 
a 4 h incubation with pancreatin + bile salts) of a commercial dry food for adult dogs 
(Vervaeke et al., 1989; modified method). 
 
Table 9.1: Analyzed chemical composition of the commercial dry dog food used in the 
study before and after enzymatic digestion (%DM)a. 
 Before digestion After digestion 
Crude protein 23.1 12.1 
Ether extract 8.6 2.0 
Starch 41.2 traces 
a Food in vitro total digestibility was 79.7% 
 
Faecal cultures were incubated at 39°C in anaerobiosis and samples were collected for 
chemical and microbiological analyses at 0, 4, 8 and 24 h. All preparations were done in an 
anaerobic cabinet.  
 
9.4 In vivo trial 
 
Nine dogs, belonging to the initial pool, screened during the first phase of the trial, 
having lactobacilli counts lower than 4,5 Log CFU for g of faeces were selected to assess 
the in vivo effect of the L. animalis strain. 
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Selected dogs received for 10 d a single oral daily dose of 0.5 g of the freeze-dried 
probiotic. Faecal samples were collected the day before probiotic administration started 
(Day 0) and again 1 and 5 d after withdrawal of the probiotic administration (Day 11 and 
15, respectively). Faecal samples were collected immediately after excretion and frozen at –
18°C within 20 min. for chemical and microbiological analyses. 
9.5 Chemical and microbiological analyses 
 
Ammonia in faecal cultures and homogenized faeces samples was measured using a 
commercial kit (Urea/BUN – Color, BioSystems S.A., Barcelona, Spain).  
Short-chain fatty acids (SCFA) in faecal cultures and homogenized faeces samples 
were analyzed by gas chromatography (Varian 3400, Varian Analytical Instruments, 
Sunyvale, CA 94089, USA) with Carbopack B-DA/4% CW 2M and 80/120 packed column 
(Supelco, Sigma Aldrich s.r.l., 20151 Milano, Italy). The faeces were homogenized and 
diluted 1:1 with distilled water and centrifuged (3,000 × g, 15 min.) and 1 mL of the 
supernatant was deproteinized with 50 µL perchloric acid (Merck, Darmstadt, Germany). 
Finally, both faecal culture and faeces supernatant samples were centrifuged (14,000 x g, 10 
min.) and added with pivalic acid as an internal standard (Fussel and McCalley, 1987) prior 
to injection. 
Immediately after sampling, faecal cultures samples were serially diluted with 
prereduced half-strength WCAB. From each of the dilutions, 0.1 mL was plated in triplicate 
onto selective media: MacConkey Agar (Merck, Darmstadt, Germany) for coliforms, OPSP 
Agar (Oxoid, Basingstoke, UK) for Clostridium perfringens, LAMVAB Agar (Hartemink et 
al., 1997) for lactobacilli, Azide Maltose Agar (Biolife, Milano Italy) for enterococci, and 
RB Agar (Hartemink et al., 1996) for bifidobacteria. All media were kept ≥ 24 h in the 
anaerobic chamber before use. MacConkey agar plates were incubated aerobically at 37°C 
for 24 h; Azide agar plates in aerobiosis for 48 h; all other media were incubated 
anaerobically at 37°C for 48-72 h. 
Within 10 days from collection, faecal samples were homogenized and plated onto the 
same selective media (with the only exception of RB Agar), following the same procedures 
previously described.  
Representative colonies grown onto LAMVAB plates were identified at genus level 
by standard bacteriological procedures (Gram stain reaction, colonial and cellular 
morphology). After genus identification, rDNA sequence of colonies apparently belonging 
to L. animalis species was determined for strain level identification 
 43 
9.6 Statistical analysis 
 
Data from the in vitro trial were analyzed using the Student-Newman-Keuls test. 
Differences were considered statistically significant at P < 0.05. 
In the in vivo trial, data from measurements at Day 0, 11 and 15 were analyzed by 
one-way ANOVA using the GLM procedure of SAS (SAS Inst., Inc., Cary, N.C.) with time 
as the main factor; the differences among means of groups were analyzed using the Student-
Newman-Keuls test. Differences were considered statistically significant at P < 0.05. 
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10. Probiotic study: Results 
 
10.1 Isolation of the probiotic strain 
 
Lactobacilli and Bifidobacteria counts in faecal cultures are reported in Table 10.1. 
 
Table 10.1: Counts of viable lactobacilli and bifidobacteria (log CFU/ml) in dog faecal 
samples, bold data correspond to subjects selected for the in vivo trial. 
 
Lactobacilli Bifidobacteria 
1 3,30 <3 
2 <3 <3 
3 6,85 6,34 
4 7,40 7,95 
5 <3 3,85 
6 <3 7,20 
7 <3 9,30 
8 3,90 3,00 
9 <3 <3 
10 5,08 5,08 
11 5,08 5,08 
12 <3 <3 
13 5,85 6,96 
14 6,85 6,98 
15 6,90 6,90 
16 4,30 <3 
17 3,72 <3 
 
Among the 17 dogs that were sampled, LAB faecal counts were higher than 105 
CFU/g in three subjects and than 106 CFU/g in four. On the contrary, of the remaining nine 
dogs, four had LAB faecal counts between 103 and 105 CFU/g and six were under the 
detection limit of 103 CFU/g. 
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10.2 In vitro trial 
 
Bacterial counts in faecal cultures are reported in Table 10.2 and Figures 
10.1,10.2,10.3,10.4 and 10.5. Ammonia and SCFA faecal concentrations and pH values are 
reported in Table 10.3 and Figures 10.6 and 10.7. 
 
Table 10.2: Counts (Log CFU/mL) of viable coliforms, enterococci, Clostridium 
perfringens, bifidobacteria, and lactobacilli in dog faecal cultures added (Lac +) or not (Lac 
-) with Lactobacillus animalis LA4. Values are the mean of four replicates ± SD. 
 0 h 4 h 8 h 24 h 
 Lac - Lac + Lac - Lac + Lac - Lac + Lac - Lac + 
Coliforms 6.67  6.67  6.62 ± 0.03 6.65 ± 0.03 6.69 ± 0.07 6.68 ± 0.02 7.27 ± 0.26 7.31 ±0.34 
Enterococci 6.40  6.40  7.71 ± 0.08 7.13 ± 0.17* 7.69 ± 0.07 6.82 ± 0.06* 7.71 ± 0.18 6.62 ± 0.20* 
Bifidobacteria 5.30 5..30 5.35 ± 0.09 5.41 ± 0.08 5.47 ± 0.08 5.76 ± 0.54 6.41 ± 0.28 6.53 ± 0.08 
C. perfringens 6.48  6.48  6.42 ± 0.13 6.33 ± 0.23 6.63 ± 0.27 6.37 ± 0.09 6.82 ± 0.21 6.33 ± 0.11* 
Lactobacilli 5.70 5.70 6.26 ±0.19 8.51 ± 0.16* 7.18 ± 0.21 9.18 ± 0.13* 8.17 ± 0.24 9.61 ± 0.18* 
L. animalis  6.18  8.51 ± 0.16  9.18 ± 0.13  9.59 ± 0.18 
* indicates a significant difference (P < 0.05) from the corresponding Lac- value 
 
Figure 10.1: Counts of viable coliforms (Log CFU/ml) in dog faecal cultures added (Lac +) 
or not (Lac -) with a strain of Lactobacillus animalis. Values are the mean of four replicates 
± SEM. 
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Figure 10.2: Counts of viable enterococci (Log CFU/ml) in dog faecal cultures added (Lac 
+) or not (Lac -) with a strain of Lactobacillus animalis. Values are the mean of four 
replicates ± SEM. 
* indicates significant difference (P < 0.05) 
 
Table 10.3: Counts of viable bifidobacteria (Log CFU/ml) in dog faecal cultures added (Lac 
+) or not (Lac -) with a strain of Lactobacillus animalis. Values are the mean of four 
replicates ± SEM. 
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Figure 10.4: Counts of viable Clostridium perfringens (Log CFU/ml) in dog faecal cultures added 
(Lac +) or not (Lac -) with a strain of Lactobacillus animalis. Values are the mean of four 
replicates ± SEM. 
* indicates significant difference (P < 0.05); 
 
Figure 10.5: Counts of viable lactobacilli (log CFU/ml) in dog faecal cultures added (Lac +) or 
not (Lac -) with a strain of Lactobacillus animalis. Values are the mean of four replicates ± SEM. 
   * indicates significant difference (P < 0.05) 
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Table 10.3: pH values and ammonia and short-chain fatty acids (mmol/l) concentrations in dog 
faecal cultures added (Lac +) or not (Lac -) with a strain of Lactobacillus animalis. Mean ± SEM. 
 4 h 8 h 24 h 
 
Lac - Lac + Lac - Lac + Lac - Lac + 
pH 6.14 ± 0.01 6.13 ± 0.01 6.12 ± 0.01 6.07 ± 0.02 5.73 ± 0.14 5.59 ± 0.02 
Ammonia 7.74 ± 0.67 8.41 ± 0.59 9.68 ± 0.57 4.10 ±0.40* 6.73 ± 0.84 9.91 ± 1.56 
Acetic acid 16.1 ± 0.47 17.3 ± 1.46 18.6 ± 1.02 18.3 ± 0.98 21.3 ± 0.88 21.5 ± 0.73 
Propionic acid 5.33 ± 0.18 5.58 ± 0.51 5.74 ± 0.31 5.82 ± 0.31 11.3 ± 0.99 11.4 ± 1.62 
isoButyric acid 0.27 ± 0.01 0.28 ± 0.02 0.26 ± 0.01 0.26 ± 0.01 0.27 ± 0.01 0.31 ± 0.02 
n-Butyric acid 1.24 ± 0.04 1.24 ± 0.10 1.22 ± 0.06 1.22 ± 0.07 2.55 ± 0.09 2.25 ± 0.40 
isoValeric acid 0.25 ± 0.01 0.25 ± 0.01 0.22 ±  0.01 0.22 ± 0.01 0.22 ± 0.01 0.25 ± 0.02 
Lactic acid 1.16 ± 0.09 1.44± 0.06* 1.57 ±  0.16 1.67 ± 0.11 0.98 ± 0.09 1.18 ± 0.16 
Total SCFA 24.4 ± 0.77 26.2 ± 2.06 27.7 ± 1.51 27.6 ± 1.41 36.7 ± 1.84 37.0 ± 2.50 
* indicates significant difference (P < 0.05); values are the mean of four replicates 
 
 
Figure 10.6: Ammonia concentration (mmol/L) in dog faecal cultures added (Lac +) or not (Lac -) 
with a strain of L. animalis. Values are the mean of four replicates ± SEM. 
   * indicates significant difference (P < 0.05) 
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Figure 10.7: pH in dog faecal cultures added (Lac +) or not (Lac -) with a strain of L. animalis. 
Values are the mean of four replicates ± SEM. 
 
Enterococci were significantly reduced and lactobacilli increased (P < 0.05) by L. animalis 
addition throughout the study. After 24 h of incubation, C. perfringens counts were significantly 
reduced in the bottles containing the L. animalis strain (P < 0.05). Bifidobacteria and coliforms 
counts were not affected by treatment. 
After 8 h of incubation, ammonia was significantly reduced (4.10 vs 9.68 mmol/L; P < 
0.001) by L. animalis. At 4 h, lactic acid concentration was significantly higher in faecal cultures 
containing the L. animalis strain (1.44 vs 1.16 mmol/L; P < 0.05). 
 
10.3 In vivo trial 
 
All dogs remained in good health during the administration of the L. animalis strain. Faecal 
microbial counts before and after administration of the probiotic strain are shown in Table 10.4 
and Figure 10.8. On Day 11, lactobacilli faecal counts were significantly higher than at trial start 
(6.99 vs. 3.35 Log CFU/g of faeces; P < 0.001). The L. animalis probiotic strain was recovered in 
all faecal samples collected on Day 11 and in faeces of four dogs out of nine at Day 15. Ammonia 
and SCFA faecal concentrations were not influenced by the probiotic strain (Table 10.5). 
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Table 10.4: Counts (Log CFU/mL) of viable coliforms, enterococci, Clostridium perfringens, 
bifidobacteria, and lactobacilli in dog faecal samples of nine dogs before (T0), 1 (T1) and 5 (T2) 
days after a 10 d administration of a strain of L. animalis. 
  
Lactobacilli Coliforms Enterococci C. perfringens 
T0 2,30 5,15 4,60 3,00 
T1 6,20 4,90 < 4 3,00 1 
T2 < 2 5,00 4,81 3,60 
T0 2,48 4,90 7,71 3,00 
T1 7,08 3,79 6,74 2,41 2 
T2 3,78 4,67 5,41 3,38 
T0 3,11 5,00 5,00 3,11 
T1 7,30 5,41 8,08 3,00 5 
T2 3,96 6,51 6,00 3,00 
T0 4,08 6,00 8,24 3,18 
T1 7,73 4,26 5,30 2,00 6 
T2 4,04 6,00 7,00 3,00 
T0 < 2 5,26 5,78 3,60 
T1 5,67 4,61 < 4 3,00 7 
T2 2,30 4,41 4,81 2,36 
T0 3,36 6,70 7,00 5,70 
T1 8,20 6,62 5,90 3,30 8 
T2 4,43 6,04 5,60 2,48 
T0 4,48 5,18 6,30 7,30 
T1 6,95 4,80 6,00 7,26 12 
T2 4,00 3,70 5,12 6,00 
T0 3,54 4,20 5,30 6,30 
T1 7,92 6,85 5,45 6,00 16 
T2 7,00 7,18 5,90 6,38 
T0 4,70 5,30 7,00 4,18 
T1 6,16 4,66 4,00 4,00 17 
T2 5,08 4,68 5,76 4,00 
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Figure 10.8: Counts of viable bacteria in the faeces of nine dogs before (day 0), 1 (day 11) and 5 
days (day 15) after a 10 days administration of L. animalis LA4 (log CFU/g); values are means ± 
S.E.M..  
  * indicates significant difference (P < 0.001) 
 
Table 10.5: Ammonia and short-chain fatty acids concentrations in the faeces of nine dogs before 
(T0), 1 (T1) and 5 (T2) days after a 10 d administration of a strain of L. animalis (mmol/L) 
 Ammonia Acetic acid Propionic acid iso-Butyric acid n-Butyric acid 
Day 0 43.8 76.3 48.8 2.02 16.2 
Day 11 43.7 71.1 40.3 2.21 17.5 
Day 15 44.7 67.0 37.3 2.15 14.8 
Pooled SEM 7.75 5.32 4.63 0.40 2.04 
Anova P 0.54 0.27 0.95 0.73 0.99 
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11. Probiotic study: Discussion 
 
11.1 In vitro trial 
 
The bacterial faecal counts of the 17 dogs screened for the selection of the animals to be 
used in the probiotic trial confirmed that a very high variability exists in the intestinal bacterial 
concentrations within the canine population. In the present study, dogs were housed in different 
environments and fed different commercial dry diets but it is known from the literature 
(Suchodolski et al., 2005) that the intestinal microflora of dogs shows big differences even among 
dogs similarly housed and fed identical diets. Moreover, while there is some evidence that the diet 
may influence the intestinal microflora composition in dogs (Zentek, 2000), Simpson et al. (2002) 
concluded that individual dogs have their own characteristic faecal bacterial microflora and that 
this is unique and stable, and not influenced by the diet.  
The strain selected for the feeding trial was identificated as L. animalis, a common 
inhabitant of canine gut (Kim & Adachi, 2007; Fujisawa & Mitsuoka, 1996).  
L. animalis was not previously studied for its probiotic properties in dogs. However, 
Ehrmann et al. (2002) tested 112 strains of lactic acid bacteria for their use as a probiotic 
supplement in poultry. Their in vitro and in vivo trials demonstrated the ability of L. animalis to 
grow in presence of bile salts, tolerate acidic pH, and persist in the crop and caecum of ducks for a 
period of 18 days. The ability to survive under low pH conditions and high bile salts 
concentrations are desirable features for a successful passage through the gastrointestinal tract, 
which is a recognized prerequisite for potential probiotics (Dunne et al., 2001). 
In another study, Chen & Yanagida (2006) found a L. animalis strain (C060203) capable of 
producing, in presence of surfactants, a bacteriocin-like inhibitory substance with a wide 
inhibitory spectrum against Gram-positive bacteria. In a study conducted by Gusils et al. (1999) 
with chickens intestinal fragments, L animalis was able to inhibit the adhesion of S. pullorum, S. 
enteritidis, and S. gallinarum to host-specific epithelial fragment. The production of substances 
capable of inhibit growth or adhesion of phatogenic microorganism is a desired characteristic of 
probiotic strains. 
These data, apart from the absence of studies in dogs, suggested a potential use as a 
probiotic for the isolated L. animalis strain. 
In the present study, addition of L. animalis determined a significant decrease of enterococci 
throughout the study and C. perfringens after 24 hours of incubation, while lactobacilli were 
significantly increased throughout the study. C. perfringens is a potential pathogen, naturally 
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harbored in the digestive tract of dogs. Some strains of C. perfringens are able to produce toxins 
which can cause diarrhoea. In the dog, C. perfringens has been associated with 28-34% of 
diarrheic cases, ranging in severity from mild to potentially fatal (Kather et al., 2005). Enterococci 
are commensal bacteria of the gastro-intestinal tract of dogs. However, they are frequently 
isolated in intestinal content of dogs with small intestinal bacterial overgrowth (SIBO) (Rutgers et 
al., 1995), and in case of nosocomial infections. Therefore, reducing the number of clostridia and 
enterococci in the intestine could decrease the risk of intestinal disease in dogs.  
The competitive exclusion of pathogens in humans and animals is a well-known beneficial 
effect of probiotics lactic acid bacteria (Rolfe, 2000; Reid and Burton, 2002). However, effects of 
various lactic acid bacteria species on intestinal pathogen bacteria are different from each other. 
Perelmuter et al. (2008, in press), in a study conducted with a strain of L. murinus isolated from 
the canine intestinal tract, demonstrated its ability to inhibit the growth of two C. perfringens and 
two E. coli strains during an agar spot test. Similarly, several strains of L. reuteri (McCoy & 
Gilliland; 2007), isolated from canine faeces, inhibited the growth of S. typhimurium. However, in 
another study conducted by Swanson et al. (2002a), a L. acidophilus strain administered to dogs 
did not affect C. perfringens and E. coli faecal concentrations. The absence, in environments like 
faecal cultures or the microbial ecosystem of the gastrointestinal tract, of significant effects on 
bacterial counts could be due to the complexity and hostility of the environment, which hardly 
could be influenced by a single bacterial strain. 
Ammonia is a toxic compound which is produced in the hindgut as a result of bacterial 
proteolytic activity and has a negative impact on intestinal mucosa and enterocytes (Blachier et 
al., 2007). In vitro, the probiotic strain reduced ammonia concentration by 58% after 8 h of 
incubation. This finding could be the consequence of the partial inhibition of proteolytic bacteria 
by the probiotic strain, as suggested by the reduction of C. perfringens observed after 24 h of 
incubation. Similarly, during a 24 h in vitro study with swine cecal chyme (Piva et al., 2005), a L. 
brevis strain reduced ammonia concentrations after 8 h of incubation but not after 24 h. Both 
studies suggest that LAB strains can reduce in vitro intestinal proteolysis and ammonia 
concentrations but that this effect disappears when energy sources such as starch and other 
fermentable carbohydrates are depleted (Russel et al., 1983). In the study by Piva et al. (2005), 
the reduction of ammonia concentrations was more effective when the tested LAB strains were 
associated to lactitol, a non-digestible disaccharide. In the present study, the dry food contained 
after enzymatic digestion only traces of starch, thus limiting the energy available to lactic acid 
bacteria. This seems to be confirmed by the fact that the addition of the probiotic did not affect pH 
and increased lactic acid only at 4 h, but not later during the study. 
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11.2 In vivo trial 
 
The faecal recovery of L. animalis LA4 used as a probiotic and the high lactobacilli faecal 
counts on day 11 showed that LA4 survived gastrointestinal passage. In fact, after 10 days of 
probiotic administration, faecal counts of lactobacilli increased by about 4 log units. On day 15, 
lactobacilli counts dropped close to their initial values. In two studies with Lactobacillus sp. 
strains in dogs (Weese and Andersen, 2002; Baillon et al., 2004), the probiotic strains were 
recovered in the faeces during administration but not a few days after. 
When the L. animalis strain was fed to adult dogs, faecal counts of C. perfringens, coliforms 
and enterococci were not significantly influenced by the probiotic. The relative low number of 
animals used in this study and the high individual variability may explain the lack of a significant 
effect of the probiotic on faecal counts of undesired microbes. However, enterococci and C. 
perfringens showed a trend towards a numerical reduction after administration of the probiotic, 
and the reduction of faecal enterococci came close to a significant difference (P of the model = 
0.08). In another study, when a Lactobacillus acidophilus strain was fed to dogs (Baillon et al., 
2004), clostridia faecal counts were significantly reduced during probiotic administration. 
Because enterotoxigenic C. perfringens can be responsible of diarrhoea in dogs (Weese et al., 
2001), lactic acid bacteria probiotics might help reducing the incidence in dogs of C. perfringens 
enteric disease and environmental shedding. The latter might be important for dog-owners, 
because C. perfringens enterotoxin has been associated with diarrhoea and food poisoning in 
humans (Li et al., 2007). 
Changes in the intestinal microflora were not reflected by differences in faecal 
concentrations of ammonia and SCFA. From the literature, it is known that the concentration of 
bacterial metabolites can vary dramatically while digesta move from the colon to the rectum, 
especially for those metabolites, such as ammonia and volatile fatty acids that are able to cross the 
intestinal mucosa and be absorbed. As such, faeces might not reflect the changes in the 
concentration of metabolites that the probiotic might have induced in the hindgut (Stevens & 
Hume, 1998). 
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12. Prebiotic study: Materials and methods 
 
12.1 In vitro fermentation 
 
Fresh faeces from eight healthy adult dogs (household dogs, different breeds, fed different 
commercial dry diets and living in different environments; between 1 and 5 years of age), which 
had not received antibiotic treatment for at least 3 months prior to experimentation, were collected 
immediately after excretion in sterile vessels, homogenized using stomacher for 5 minutes, and 
then suspended 10% (w/v) in half-strength pre-reduced Wilkins Chalgren Anaerobe Broth 
(WCAB 0.5x).  
Faecal suspension was used to inoculate (3,3% v/v) five 30 mL anaerobic serum bottles 
(containing 21 mL of medium prepared according to Sunvold et al., 1995), and five 10 mL glass 
syringes (containing 4,85 mL of medium) per treatment.  
The composition of the medium used to culture the microflora is presented in Table 12.1. 
All medium components, except the vitamin mixes, were added before autoclaving. The vitamin 
mixes were aseptically added after they were filter-sterilized. 
 
Table 12.1: Composition of medium used (Sunvold et al., 1995, modified). 
Component Concentration in medium 
 ml/L 
Solution A (1) 330.0 
Solution B (2) 330.0 
Trace mineral solution (3) 10.0 
Water-soluble vitamin mix (4) 20.0 
Folate:biotin solution (5) 5.0 
Riboflavin solution (6) 5.0 
Hemin solution (7) 2.5 
Distilled water 302.5 
 g/L 
Yeast extract 0.5 
Trypticase 0.5 
Na2CO3 4.0 
Cisteyn HCl H2O 0.5 
(1)
 Composition g/L: NaCl, 5.4; KH2PO4 2.7; CaCl2 H2O 0.16; MgCl2 6H2O, 0.12; MnCl2 4H2O, 0.06; CoCl2 6H2O, 0.06; 
(NH4)2SO4, 5.4. (2)
 Composition g/L: K2HPO4, 2,7. (3)
 Composition mg/L: EDTA (disodium salt), 500; FeSO4 7H2O, 200; ZnSO4 7 H2O, 10; MnCl2 4 H2O, 3; H3PO4, 30; CoCl2 6 
H2O, 20; CuCl2 2H2O, 1; NiCl2 6H2O, 2; Na2MoO4 2H2O, 3. (4)
 Composition mg/L: thiamin HCl, 100; d-pantothenic acid, 100; niacin, 100; Pyridoxine, 100; p-aminobenzoic acid, 5; vitamin 
B12, 0,25. (5)
 Composition mg/L: folic acid, 10; d-biotin, 2; NH4HCO3, 100. (6)
 Composizione: riboflavin 10 mg/L in 5 mmol/L of HEPES. 
(7)
 Hemin, 500 mg/L in 10 mmol/L NaOH. 
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Bottles and syringes also contained an in vitro digested commercial dry food for dogs at the 
final concentration of 10 g/L. The in vitro digested food simulates the undigested fraction of the 
diet that reaches the hindgut and is obtained by in vitro digestion (2 h incubation with HCl + 
gastric lipase + pepsin followed by a 4 h incubation with pancreatin + bile salts) of a commercial 
dry food for adult dogs (Vervaeke et al., 1989; modified method) (Table 12.2).  
 
Table 12.2: Analyzed chemical composition of the commercial dry dog food used in the study 
before and after enzymatic digestion (%DM)a. 
 Before digestion After digestion 
Crude protein 20.5 10.3 
Ether extract 11.4 2.4 
Starch 42.2 traces 
a Food in vitro total digestibility was 78.1% 
 
In total, 6 substrates were studied: fructo-oligosaccharides (FOS), inulin, pectins, gluconic 
acid, lactitol, and a fiber rich ingredient (chicory). Substrates were added at the final concentration 
of 1g/L (inulin, FOS, pectin, lactitol, gluconic acid) or 4g/L (chicory). These concentrations 
should reflect the amount of fiber that reaches the hindgut when non-digestible oligosaccharides 
(NDO) and fiber-rich ingredients are included in the feed at a concentration of 1% and 4%, 
respectively. In fact, if we estimate that the average digestibility of a commercial dry food for 
dogs is 90% and assuming that all soluble fiber will reach the large intestine, the ratio between the 
undigested food fraction (in vitro digested diet) and the soluble fiber source in the hindgut will 
approximately be 10:1 for NDO and 10:4 for fiber-rich ingredients. 
Five bottles and five syringes were prepared without any experimental substrate as a 
negative control, while lactitol was used as positive control in all the experiments. 
Faecal cultures (bottles and syringes) were incubated for 24 h at 39°C under anaerobic 
conditions and samples of fermentation fluid were collected from each bottle at 0, 6, and 24 hours 
for analysis (ammonia, SCFA, pH, lactobacilli, enterococci, coliforms).  
Gas production was measured as described by Menke et al. (1979) measuring the amount of 
gas produced in the glass syringes throughout the 24 h of the study.  
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12.2 Chemical and microbiological analyses 
 
Ammonia in samples of fermentation fluid was measured using a commercial kit 
(Urea/BUN – Color, BioSystems S.A., Barcelona, Spain).  
Short-chain fatty acids (SCFA) in samples of fermentation fluid were analyzed by gas 
chromatography (Varian 3400, Varian Analytical Instruments, Sunyvale, CA 94089, USA) with 
Carbopack B-DA/4% CW 2M and 80/120 packed column (Supelco, Sigma Aldrich s.r.l., 20151 
Milano, Italy). The samples of fermentation fluid were centrifuged (3,000 × g, 15 min.) and 1 mL 
of the supernatant was deproteinized with 50 µL perchloric acid (Merck, Darmstadt, Germany). 
Finally, samples of fermentation fluid were centrifuged (14,000 x g, 10 min.) and added with 
pivalic acid as an internal standard (Fussel and McCalley, 1987) prior to injection. 
The second sample of fermentation fluid was homogenized and serially diluted with 
prereduced half-strength WCAB 0.5x. From each of the dilutions, 0.1 mL was plated in triplicate 
onto selective media: MacConkey Agar (Merck, Darmstadt, Germany) for coliforms, LAMVAB 
Agar (Hartemink et al. 1997) for lactobacilli, and Azide Maltose Agar (Biolife, Milano Italy) for 
enterococci. MacConkey agar plates were incubated aerobically at 37°C for 24 h; Azide agar 
plates in aerobiosis for 48 h; LAMVAB Agar plates were incubated anaerobically at 37°C for 48 
h. 
 
12.3 Statistical analysis 
 
A modified Gompertz bacterial growth model was used to fit gas production data and obtain 
the following gas production parameters: total gas production (mL, the amount of gas produced 
during the 24 h study), maximum rate of gas production (mL/h, the highest velocity reached by 
gas production), log time (h, the duration of gas production phase), and lag time (h, the time 
between fermentation start and when bacteria start producing gas) 
Gas production parameters, ammonia, pH, and SCFA data, as well as counts of coliforms, 
lactobacilli, and enterococci were analyzed by one-way ANOVA, with the Dunnett test as the post 
test. Each syringe and bottle formed the experimental unit. Differences were considered 
statistically significant at P<0,05. 
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13. Prebiotic Study: Results 
 
Gas production parameters, pH, SCFA concentrations, and ammonia data are reported from 
Figure 13.1 to Figure 13.4. Major SCFAs proportion are reported in Table 13.1. 
Counts of viable coliforms, lactobacilli and enterococci are reported from Figure 13.5 to 
Figure 13.7. 
 
Figure 13.1: Gas production parameters. Values are the means of five replicates ± SEM.  
Legend: 
• a: total gas production 
• b: maximum rate of gas production 
• c: lag time 
• d: log time 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
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Figure 13.2: : pH in faecal slurry. Values are means of five replicates ± SEM. 
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Legend: 
• a: 6 h 
• b: 24 h 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
 
FOS, inulin, gluconic acid and lactitol significantly increased total gas production, 
compared with the control diet (+ 45%, + 50%, +68%, and +26%, respectively). While FOS, 
inulin, and gluconic acid increased velocity of gas production (+ 33%,+37%, and +107%, 
respectively), pectin resulted in lower velocity than control (- 30%). Pectin and lactitol determined 
a significant increase in the duration of the Log phase (+ 65%, and + 34%, respectively). 
pH was significantly reduced by FOS throughout the study, while pectin, chicory, and 
lactitol significantly reduced pH after 24 hours of fermentation. 
After 24 hours of fermentation total SCFA were significantly increased by pectin, inulin, 
and lactitol (+ 15%, +17%, and +19%, respectively). Pectin also increased acetic acid (+31%), 
lactic + propionic acid (+63%), and n-butyric acid (+36%) concentrations. Lactitol determined a 
significant increase in acetic acid (+10%), while propionic + lactic acid showed only a tendency to 
increase (P = 0.0537). The addition of inulin resulted in a significant increase in n-butyric acid 
(+34%) and in a tendency to increase of acetic acid (P = 0.0876). FOS and chicory did not affect 
SCFA concentrations. Gluconic acid determined a significant reduction of propionic + lactic acid 
concentration (-40%). 
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Figure 13.3: SCFA in faecal slurry (mmol/L). Values are means of five replicates ± SEM. 
Legend:  
• a: concentration of total SCFA in faecal slurry 
• b: acetic acid concentration; 
• c: lactic + propionic acid concentration; 
• d: iso-butyric acid concentration; 
• e: nor-butyric acid concentration; 
• f: iso-valerianic acid concentration 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
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Table 13.1: Molar proportion of major SCFA (acetate : propionate+lactate : butyrate). Values are 
means of five replicates ± DS. 
 Acetic Propionic+lactic Butyric 
Control 55.7 ± 2.49 30.5 ± 2.69 13.9 ± 0.91 
FOS 49.4 ± 2.18 * 37.1 ± 2.14 * 13.5 ± 0.90 
Pectin 57.2 ± 1.79 28.0 ± 1.99 14.8 ± 2.28 
Inulin 52.6 ± 0.35 32.0 ±0.28 15.4 ± 0.16 
Chicory 55.8 ± 2.69 30.8 ± 2.94 13.3 ± 0.73 
Gluconic acid 55.8 ± 0.97 26.8 ± 0.81 17.5 ± 0.80 * 
Lactitol 52.1 ± 5.68 * 36.2 ± 6.53 * 11.6 ± 1.40 * 
* indicates significant difference (P < 0.05) 
 
The addition of FOS and lactitol determined a significant decrease in the molar proportion 
of acetic acid, while increased propionate + lactate one; lactitol reduced also butyrate molar 
proportion. Gluconic acid significantly increased butyrate molar proportion. 
 
Figure 13.4: Ammonia concentration in faecal slurry (mmol/L). Values are means of five 
replicates ± SEM. 
Ct
r
FO
S
Pe
cti
n
Inu
lin
Ch
ico
ry
Gl
uc
on
ic a
cid
La
cti
tol
25.0
27.5
30.0
32.5
35.0
a
N
H
3 
(m
m
ol
/L
)
Ct
r
FO
S
Pe
cti
n
Inu
lin
Ch
ico
ry
Gl
uc
on
ic a
cid
La
cti
tol
30
35
40
45
**
b
N
H
3 
(m
m
ol
/L
)
 
Legend: 
• a: 6 h 
• b: 24 h 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
 
Ammonia concentration in the faecal slurry wasn’t affected by the addition of any prebiotic 
substance after 6 hours of fermentation, while it was significantly increased by gluconic acid after 
24 hours. 
 
 62 
Figure 13.5: Counts of viable coliforms (Log CFU/mL).  
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Legend: 
• a: 6 h 
• b: 24 h 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
 
Figure 13.6: Counts of viable enterococci (Log CFU/mL).  
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Legend: 
• a: 6 h 
• b: 24 h 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
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Figure 13.7: Counts of viable lactobacilli (Log CFU/mL). 
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Legend: 
• a: 6 h 
• b: 24 h 
* indicates significant difference (P < 0.05) 
** indicates significant difference (P < 0.01) 
 
Addition of FOS, after 6 and 24 h of fermentation, and pectin, after 6 h, significantly 
increased enterococci counts. Lactitol, after 24 h of fermentation, determined a significant 
reduction in coliforms; moreover, at the same time point, lactitol significantly increased 
lactobacilli. After 24 h of fermentation, the addition of inulin, while having no effect on 
enterococci end coliforms counts, significantly decreased lactobacilli counts. Lactobacilli counts 
were higher than control with supplemented chicory and lactitol (P < 0.05) after 24 hours of 
fermentation, and tended to be grater after 6 hours of fermentation with lactitol (P = 0.0701). 
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14. Prebiotic study: Discussion 
 
In in vitro systems, gas production is generally recognized as a product, and an index, of the 
activities of the total microflora present in the fermentors. The amount and composition of gas 
produced could be affected by many variables such as the chemical structure of the carbohydrate 
(chain length, monosaccharide compositions) as well as the composition of the fermentative 
microflora (Spears et al., 2007). In literature few data exist about the gas production properties of 
prebiotic substances, and rarely data are compared to a negative control. In a study by Ghoddusi et 
al. (2007), who evaluated the effects of different carbohydrate sources on gas production by 
human fecal inocula, inulin determined the highest gas production compared to other 
carbohydrates, particularly if compared to FOS, which produced the lower amount of gas. Rycroft 
et al. (2001), comparing the prebiotic properties of several oligosaccharides using human fecal 
microflora, found the highest levels of gas production with inulin, lactulose, FOS and XOS. In a 
previous study by Piva et al. (1996) with swine cecal microflora, lactitol, compared to a negative 
control, determined a significant increase in the amount of gas produced when added to a low-
fiber diet. In our study, inulin, FOS, gluconic acid, and lactitol increased the amount of gas 
produced, while pectins and chicory did not; conversely, in an in vitro trial with a canine fecal 
inoculum conducted by Swanson et al. (2001), pectins, when compared with fruits and vegetables 
fibers, determined the highest amount of gas production.  
The discrepancy of some results obtained in the present trial with those reported from 
previous studies could be explained taking into account two main factors. First of all, we have to 
consider the “bifidogenic nature” of prebiotics which, in fact, selectively stimulate bifidobacteria 
(Gibson et al., 1994). Bifidobacteria are not frequently isolated from dog faeces. Kim & Adaki 
(2007) screened 36 samples of dog faeces for lactic acid bacteria and bifidobacteria counts and 
found bifidobacteria only in 6.8% of the samples. In the study by Greetham et al. (2002) 
bifidobacteria were not detectable at all in the faeces of four dogs. Therefore, the inconstant 
presence of bifidobacteria in the experimental faecal inoculum could explain the different results 
obtained in different studies.  
Moreover, the different chemical structure of each prebiotic could affect the selectivity and 
intensity of fermentation. Roberfroid (2001) compared the fermentation of inulin and FOS by 
different bacterial specie; in his study, FOS were more intensely fermented by all the bacterial 
species tested, resulting in a lower selectivity of fermentation but in a higher intensity. A similar 
comparison, between FOS and inulin, was conducted by van de Wiele et al. (2007), who obtained 
the same results of Roberfroid (2001). Fructans of longer chain length, like inulin, are less (or 
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more slowly) fermentable than compounds of shorter chain length. However, if administered for 
longer periods of time they show a more pronounced beneficial effect than oligofructoses of a 
shorter chain length (van de Wiele et al., 2007). Olano-Martin et al. (2002) investigated the 
prebiotic properties of pectins and pectic-oligosaccharides (obtained from controlled hydrolysis of 
pectins) with different degrees of esterification. In this case, too, molecules with shorter chain 
length (pectic-oligosaccharides) were more intensely fermentable. Moreover, the authors detected 
a clear influence of the degree of esterification on fermentation, with highly methylated carbon 
sources giving lower growth rates than the lower methylated ones.  
Among the substrates tested in the present study, pectin, inulin, and lactitol significantly 
increased total SCFA concentrations after 24 hours of fermentation (Figure XX). It is well 
konown that substrates (dietary fibre) which escape digestion and reach the terminal tract of the 
intestine are broken down by the resident microflora to the SCFA acetate, propionate, butyrate 
and the gases hydrogen and carbon dioxide (Wang & Gibson, 1993). Lactate is an intermediate 
which is also converted to SCFA by the intestinal microflora (Hume et al., 1995). When SCFA 
are produced by bacterial fermentation in the intestine they are rapidly absorbed, with only 5% to 
10% being excreted in the faeces (Ruppin et al., 1980). The role of SCFA comprehends various 
local and systemic effects. Increases in intestinal SCFA results in decreased pH, which influences 
the composition of colonic microflora, increases absorption of minerals (butyrate and propionate 
stimulate fluid absorption of calcium, magnesium, and other cations in the colon; Scholtz-Arhens 
& Schrezenmeir, 2002) and reduces ammonia absorption by the protonic dissociation of ammonia 
and others amines (Cummings, 1981). Of the three major SCFA produced (acetate, propionate, 
and butyrate), butyrate is the major energy source for the colonocytes and exerts an important 
trophic effect increasing colonic crypt depth (Velázquez et al., 1997).  
Published data about the influence on SCFA production of the addition of prebiotic 
substances in dog are contrasting and, above all, few works reported a direct comparison against a 
control (no supplemental prebiotic) on SCFA production. Flickinger and co-workers (2003) and 
Propst and co-workers (2003) studied the effects of the addition of oligofructose in the diet of 
dogs. Propst et al. (2003) detected a significant increase of all the SCFA produced, compared to 
the control group, while Flickinger et al. (2003) reported a significant increase only in propionate 
concentration. The different results could be explained by differences in the intestinal microbial 
population of the dogs that have been used. Other studies (Sunvold et al., 1995; Vickers et al., 
2001; Swanson et al., 2001) reported in literature compare the effects of several prebiotic 
substances without any control group. These results are hardly interpretable because none of the 
studies provide a “no addition effect” to which compare “prebiotic” results.  
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Molar proportion of SCFA can provide additional information about the quality of the 
substrate. In our study, molar proportions of butyric acid were low, compared with average data 
from the literature (60:20:20) (Cummings et al., 1979), for all substrates tested. The carbohydrates 
present in the diet could influence not only the amount but also the molar proportion of the acid 
produced during fermentation. Carbohydrates that are reported in literature to stimulate the 
formation of butyric acid are resistant starch fractions and β-glucans, while pectin and xylan are 
associated with low butyrate-high acetate production (Knudsen et al., 2003). In our study, FOS 
and lactitol determined a significant increase of the molar proportion of propionic + lactic acid, 
accompanied by a proportional reduction of acetic acid. FOS behaviour was in agreement with 
data from the literature. In fact, Vickers et al. (2003) and Liong & Shah (2005) reported a similar 
variation in SCFA molar proportion after the addition of FOS. Conversely, lactitol data are in 
disagreement with the findings of Nilsson & Nyman (2005) who reported different molar 
proportions. Macfarlane & Gibson (1995) demonstrated that environmental and microbial 
variables, particularly carbonium availability and growth rate, could affect SCFA production by 
pure cultures of colonic microorganism. Their results showed that, in different experimental 
conditions, the same bacterial specie can produce different SCFA molar ratios from the same 
substrate..  
After 24 hours of fermentation, BCFA were lowered by the addition of FOS, inulin, 
gluconic acid, and lactitol. Branched SCFAs (iso-butyrate and iso-valerate) are, together with 
ammonia, phenols and amines, the end-products of the fermentation of dietary proteins and amino 
acids by proteolytic bacteria and are responsible for the odour of faeces. At 24 h, FOS, inulin, 
gluconic acid and lactitol significantly reduced iso-butyrate concentrations (P < 0.001) and FOS 
and gluconic acid also reduced iso-valerate concentration (P < 0.001).  
Gluconic acid significantly increased ammonia concentration after 24 h of fermentation, 
while the other treatments did not affect ammonia concentration. Literature data about the 
ammonia concentration during prebiotic trials are contrasting. Propst et al. (2003) detected a 
significant increase in ammonia concentration in the faeces of dogs fed oligofructose and inulin 
enriched diets, while in a study by Flickinger et al. (2003) ammonia concentration tended to 
decrease in the faeces of dogs fed the oligofructose supplemented diet. Ammonia is a product of 
protein catabolism by bacteria. In close systems, like fermentors, energy sources such as starch 
and other fermentable carbohydrate are rapidly depleted in the initial phase of the fermentation, 
and protein becomes an energy source for bacterial metabolism.  
When lactitol was used, lactobacilli tended to increase after 6 hours and significantly 
increased after 24 hours, while, at the same time point, coliforms were significantly decreased. 
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These results are in agreement with some data from literature. Chen et al. (2007) investigated the 
effects of lactitol on intestinal microflora of healthy humans and reported a significant increase in 
lactobacilli and bifidobacteria after three weeks of administration. A similar study was conducted 
by Ballongue et al. (1997), who detected an increase of probiotic bacteria and a decrease of 
putrefactive bacteria after the administration of lactitol. Finney et al. (2007), on the contrary, did 
not find any significant effects of lactitol on lactobacilli and enterobacteriaceae, but only a 
significant increase in bifidobacteria. On the other hand, other studies reported opposite results. 
Probert et al. (2004) investigated the effects of lactitol on human microflora using an in vitro 
model. In their study, lactitol determined a significant decrease of bifidobacteria and bacteroides 
and an increase in clostridia.  
Chicory, apart from the absence of any sign of increased bacterial activity, determined a 
significant increase of lactobacilli after 24 hours of fermentation, while inulin determined a 
significant decrease in lactobacilli at the same time point. The latter is in disagreement with data 
from literature (van de Wiele et al., 2007) which report an increase in lactobacilli counts in 
presence of inulin. FOS significantly increased enterococci after 6 and 24 hours of fermentation. 
These findings could be explained by the lack of selectivity of FOS, as previously reported by 
Robertfroid (2001) and van de Wiele et al. (2007). Also pectin determined a significant increase 
in enterococci counts after 6 hours of fermentation. Langhout et al. (1999) tested the effects of 
two differently methylated citrus pectins on the intestinal microflora of broilers. The effects of 
pectins varied on the basis of the degree of methylation. The high-methylated one determined a 
significant increase in enterococci, bacterioides, clostridia and E. coli; the low-methylated one 
increased only the clostridia number. Gluconic acid determined a significant increase in coliforms 
counts after 24 hours of fermentation. Few data are present in literature about the effects of 
gluconic acid on intestinal microflora. In a previous study, Biagi et al. (2006) evaluated the effects 
of gluconic acid on swine intestinal microflora using an in vitro system. The authors detected no 
significant effect of gluconic acid on microflora at any concentration tested. 
As previously stated, the initial bacterial population plays a major role in determining the 
prebiotic results. In fact, bacterial population composition at the beginning of the study could 
affect the microbial balance reached at the end, particularly in short-time studies, as in vitro ones 
are, which not supply an adequate adaptation period to the microflora.  
On the basis of data collected in the present study lactitol could be considered as a potential 
prebiotic for dogs. Other substrates need to be tested in other trial to confirm the positive results 
obtained in the present study and to further investigate the doubtful results. 
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15. Conclusions 
 
Digestibility study 
 
Results from the present study show that the in vitro method developed to predict dog foods 
digestibility can be considered as an affordable alternative to in vivo digestibility trials, thus 
reducing the utilization of dogs as experimental animals. Nevertheless, further studies will be 
needed to confirm the positive results observed in this trial. 
 
Probiotic study 
 
The present study indicates that the isolated Lactobacillus animalis strain (LA4) was able to 
survive gastrointestinal passage and transitorily colonized the dog intestine. In vitro, the L. 
animalis strain positively influenced composition and metabolism of the intestinal microflora of 
dogs. These results suggest that L animalis LA4 can be considered as a potential probiotic for 
dogs. 
 
Prebiotic study 
 
Among the tested substrates, lactitol reduced intestinal coliforms and increased lactobacilli. 
Moreover, lactitol promoted the production of SCFA and decreased the production of BCFA. 
Further studies, in particular in vivo studies with dogs, will be needed to confirm the prebiotic 
properties of lactitol and to evaluate the optimal level of its inclusion in a dog diet. 
Furthermore, more investigation is needed to evaluate the properties of the other substrates 
and achieve a better understanding of their effects on the dog intestinal ecosystem. 
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